Page last updated: 2024-09-04

beta-lactams and Bacterial Infections

beta-lactams has been researched along with Bacterial Infections in 312 studies

Research

Studies (312)

Timeframe	Studies, this research(%)	All Research%
pre-1990	60 (19.23)	18.7374
1990's	22 (7.05)	18.2507
2000's	116 (37.18)	29.6817
2010's	90 (28.85)	24.3611
2020's	24 (7.69)	2.80

Authors

Authors	Studies
De Rosa, M; Marabotti, A; Soriente, A; Verdino, A	1
Christensen, SB	1
Alegria, W; Bixby, DL; Gregg, KS; Marini, BL; Nagel, J; Perissinotti, A	1
Andersson, DI; Fatsis-Kavalopoulos, N; Roelofs, L	1
Cao, H; Chow, KH; Ho, PL; Jiang, S; Liu, MC; To, KK; Tong, MK; Tse, CW	1
Cai, J; Cui, W; Dong, Z; Gao, Y; Li, H; Liu, F; Tang, K; Wang, L; Zhang, G; Zhang, K; Zheng, C; Zhong, L; Zhou, H	1
Gao, Y; Han, T; Liu, H; Qian, B; Zhang, X	1
Carnoy, C; Faveeuw, C; Mondemé, M; Sirard, JC	1
Ates, HC; Brasier, N; Cotta, MO; Dincer, C; Eckstein, J; Gao, W; Goldhahn, J; Roberts, JA; Sempionatto, JR; Widmer, AF	1
Clark, CM; Kiel, A; Mason, J; Mergenhagen, KA; Sellick, JA; Wattengel, BA; White, A	1
Andrews, K; Ellwood, D; Grimwood, K; Heffernan, AJ; Kumar, A; Lipman, J; Roberts, J; Sime, FB; Sun, J	1
Page, MGP	1
Cardoso, T; Silva-Nunes, J	1
Gudiño Gomezjurado, ME; Latorre-Barragan, MF; Zurita-Leal, AC	1
Bradford, PA; Bush, K	1
Černý, D; Halačová, M; Sadilová, K	1
Hirao, K; Kato, A; Kawakami, J; Naito, T; Yagi, T	1
Berthomieu, D; De Luca, F; Docquier, JD; Feller, G; Galleni, M; Gavara, L; Gresh, N; Hernandez, JF; Legru, A; Marcoccia, F; Mercuri, PS; Nauton, L; Sannio, F; Sevaille, L; Tanfoni, S; Verdirosa, F	1
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y	1
Cardoso, MH; Costa, BO; Franco, OL	1
Barbosa, G; Barreiro, EJ; Lima, LM; Silva, BNMD	1
Marsot, A	1
Aditham, AK; Cava, F; Espaillat, A; Kim, J; Muriel-Mundo, C; Rivera, SL; Shieh, P; Siegrist, MS	1
Egorov, AM; Rubtsova, MY; Ulyashova, MM	1
Barragán-Prada, H; Cantón, R; Cobo, J; Del Campo, R; Escudero-Sánchez, R; Morosini, MI; Ponce-Alonso, M	1
Cheng, W; Hutton, B; Joshi, A; Kanji, S; MacDonald, E; Stevens, A; Thabet, P	1
Gatti, M; Pea, F	1
Holland, P; Jahnke, N	1
Ariza, A; Barrionuevo, E; Doña, I; Fernandez, TD; Laguna, JJ; Mayorga, C; Montañez, MI; Moreno, E; Posadas, T; Salas, M; Torres, MJ	1
Delattre, IK; Dugernier, T; Hites, M; Jacobs, F; Laterre, PF; Spapen, H; Taccone, FS; Tulkens, PM; Van Bambeke, F; Wallemacq, PE	1
Kanafani, ZA; Kanj, SS; Rizk, NA; Tabaja, HZ	1
Har, D; Solensky, R	1
Buscher, H; Gentili, S; Imani, S; Marriott, D; Sandaradura, I	1
Rotondo, CM; Wright, GD	1
Hatti, M; Odenholt, I; Resman, F; Solomonidi, N; Tham, J	1
Jett, R; Lopez, J; O'Donnell, JN; Rhodes, NJ; Scheetz, MH	1
Grundy, C; Habayeb, H; Rangaiah, J; Van de Velde, S	1
Amoroso, AM; D'hooghe, M; Decuyper, L; Deketelaere, S; Gobec, S; Joris, B; Jukič, M; Sauvage, E; Sosič, I; Vanparys, L; Verlaine, O	1
Cecchini, J; Habibi, A; Hulin, A; Mekontso Dessap, A; Razazi, K	1
Bobola, V; Forbes, W; Frazier, W; Joyner, ML; Manning, CC	1
Alfieri, A; Cascella, M; Damiani, G; Fiore, M; Kelly, ME; Leone, S; Pace, MC; Pezone, I	1
Chen, H; Yu, L; Yu, Z	1
Falagas, ME; Kapaskelis, A; Karageorgopoulos, DE; Tansarli, GS	1
Kim, DH; Yoon, H	1
Falagas, ME; Ikawa, K; Tansarli, GS; Vardakas, KZ	1
Gupta, N; Rodrigues, C; Shetty, A; Soman, R	1
Maesschalck, J	1
Carvalho, VC; Lima, AL; Oliveira, PR; Peixoto de Miranda, EJ	1
Bandettini, R; Buffa, P; Castagnola, E; Caviglia, I; Ciucci, A; Ginocchio, F; Guida, E; Haupt, R; Loy, A; Masa, DL; Mattioli, G; Perotti, M; Pini Prato, A	1
Kuti, JL; MacVane, SH; Nicolau, DP	1
Grozinsky-Glasberg, S; Lador, A; Leibovici, L; Paul, M	1
Akova, M; Bassetti, M; De Waele, JJ; Dimopoulos, G; Kaukonen, KM; Koulenti, D; Lipman, J; Martin, C; Montravers, P; Paul, SK; Rello, J; Rhodes, A; Roberts, JA; Starr, T; Wallis, SC	2
Craig, WA	1
Kwa, AL; Lee, W; Liew, Y; Teo, J	1
He, Y; Huang, L; Lu, X; Nie, S; Wu, R; Xia, C; Zhang, L	1
Elphick, HE; Jahnke, N	1
Ghafourian, S; Sadeghifard, N; Sekawi, Z; Soheili, S	1
Kuti, JL; MacVane, SH; Rhodes, NJ; Scheetz, MH	1
Akova, M; Bassetti, M; De Waele, JJ; Dimopoulos, G; Kaukonen, M; Koulenti, D; Lipman, J; Martin, C; Montravers, P; Rello, J; Rhodes, A; Roberts, JA; Starr, T; Udy, AA; Wallis, SC	1
Póvoa, P; Spriet, I; Zahar, JR	1
Avni, T; Leibovici, L; Paul, M; Shiber, S; Yahav, D	1
Ghosh, C; Haldar, J; Konai, MM; Samaddar, S; Yarlagadda, V	1
Chmura, A; Deborska-Materkowska, D; Durlik, M; Kierzkowska, M; Majewska, A; Mlynarczyk, A; Mlynarczyk, G; Paczek, L; Sawicka-Grzelak, A	1
Falagas, ME; Trigkidis, KK; Vardakas, KZ	1
Cheung, AL; Memmi, G; Monteiro, JM; Nair, DR; Pinho, MG; Pucci, M; Schwartzman, J; Thanassi, J	1
Affaticati, M; Daali, Y; Fathi, M; Harbarth, S; Huttner, A; Huttner, BD; Karmime, A; Lew, D; Pagani, L; Pugin, J; Renzoni, A; Von Dach, E	1
De Waele, JJ; Lipman, J; Udy, AA	1
García-Vázquez, E; Gómez, J; Hernández-Torres, A	1
Carlier, M; De Waele, JJ; Lipman, J; Roberts, JA	1
Coursin, DB; Fish, JT; Gravenstein, N; Klinker, KP	1
Gordon, RJ	1
Olsen, I	1
Brun-Buisson, C; Chastre, J; Leone, M; Lesprit, P; Lucet, JC; Paugam-Burtz, C; Ruppe, E; Timsit, JF; Weiss, E; Zahar, JR	1
Chemaly, RF; Mahajan, SN; Nesher, L; Rolston, KV; Tverdek, FP	1
Harbarth, S; Hope, WW; Huttner, A; Lipman, J; Roberts, JA	1
Carlier, M; De Waele, JJ; Lipman, J; Roberts, JA; Stove, V; Verstraete, AG; Wallis, SC	1
Jeffres, MN; Narayanan, PP; Schramm, GE; Shuster, JE	1
Almayah, AA; Bolandnazar, Z; Ebrahimi, A; Ebrahimi, HP; Hadi, JS; Swadi, AG	1
Gan, WJ; Mu, SM; Ran, XW; Shen, JF; Wang, J; Xian, Y; Xu, ZR; Yan, XD; Yuan, GY; Zhang, BS	1
Gandra, S; Klein, EY; Laxminarayan, R; Malhotra-Kumar, S; Pant, S	1
Damer, KM; Roman, C; Solh, T	1
Aktas, Z; Altinkanat, G; Altun, B; Aydemir, S; Gorur, H; Gunaydin, M; Gur, D; Karadag, A; Kayacan, C; Morrissey, I; Soyletir, G; Torumkuney, D; Tunger, A	1
Pratt, RF	1
Grupper, M; Kuti, JL; Nicolau, DP	1
Pintado, V	1
Evans, D; Horn, P; Lee, P; Marsh, A; Slepavicius, A; Solomkin, J; Sutcliffe, JA; Tsai, L	1
Elphick, HE; Scott, A	1
Gobernado, M; González-Esteban, J; Redondo, E; Sanz-Rodríguez, C; Torroba, L; Villanueva, R	1
Levin, AS; Oliveira, MS	1
Abbanat, D; Bush, K; Morrow, B	1
Cohen, R	1
Ansaloni, L; Catena, F; Gazzotti, F; Nanetti, A; Nardo, B; Pezzilli, R; Pinna, AD; Santini, D	1
Abramson, MA; Citron, DM; Goldstein, EJ; Merriam, CV	1
Gudiol, F; Suárez, C	1
Elliott, DJ; Keren, R; Loh, A; Troxel, AB; Zaoutis, TE	1
Hawkey, PM; Jonas, D; Khan, HM; Malik, A; Shahid, M; Singh, A; Sobia, F	1
Livermore, DM	2
Fisher, JF; Mobashery, S	1
Leibovici, L; Paul, M; Svetitsky, S	1
Brook, I	1
Childs, S; Colgan, R; Gomolin, IH; Gould, M; Gupta, K; Hooton, TM	1
Hanslo, D; King, A; Phillips, I; Shannon, K; Warren, C	1
Acred, P; Ryan, DM; Sowa, MA; Watts, CM	1
Carmeli, Y; Jansen, JP; Kumar, R	1
Bazan, JA; Kaye, KM; Martin, SI	1
An, MM; Chen, ML; Jiang, YY; Liu, P; Shen, H; Wang, R; Zhang, JD; Zou, Z	1
Hope, WW; Lipman, J; Roberts, JA	1
Lipman, J; McWhinney, B; Paterson, DL; Roberts, JA; Roberts, MS; Ulldemolins, M; Ungerer, J	1
Bush, K; Macielag, MJ	1
Fisher, JF; Llarrull, LI; Mobashery, S; Testero, SA	1
Plattner, B; Stockner, I; Wiedermann, CJ	1
Jovetic, S; Marcone, GL; Marinelli, F; Tramper, J; Zhu, Y	1
Alkan, F; Borum, E; Cetin, C; Dagalp, SB; Nak, D; Nak, Y; Tuna, B	1
Blasi, F; Concia, E; Mazzei, T; Moretti, AM; Nicoletti, G; Novelli, A; Tempera, G	2
Andresen, D; Burbury, K; Dawson, L; Kelly, A; Lingaratnam, S; O'Reilly, M; Slavin, MA; Tam, CS; Thursky, KA; Turnidge, J; Worth, LJ	1
Elphick, H; Leibovici, L; Marcus, R; Paul, M	1
Ishii, Y; Kouyama, Y; Tateda, K; Ueda, C; Yamaguchi, K	1
Pappas, G	1
Ansaloni, L; Catena, F; Coccolini, F; Di Saverio, S; Ercolani, G; Gazzotti, F; Lazzareschi, D; Pinna, AD	1
Espino-Hernández, M	1
Kirkpatrick, CM; Lipman, J; Mohd Hafiz, AA; Roberts, JA; Staatz, CE	1
Coleman, K	1
Beloborodov, VB	1
Borde, J; de With, K; Kern, WV; Stocker, H	1
Heizmann, P; Heizmann, WR; Lode, H	1
Briscoe, SE; Lipman, J; McWhinney, BC; Muller, MJ; Paratz, J; Patel, BM; Paterson, D; Roberts, JA; Rudd, M; See, NC; Ungerer, J	1
Beumier, M; Cotton, F; De Backer, D; Hites, M; Jacobs, F; Lorent, S; Roisin, S; Seyler, L; Surin, R; Taccone, FS; Vincent, JL; Wolff, F	1
Hayashi, Y; Lipman, J; Lust, K; McWhinney, B; Ng, M; Roberts, JA; Udy, AA; Ungerer, J	1
Burian, A; Burian, B; Höferl, M; Jäger, W; Riedl, M; Sauermann, R; Stella, A; Theurer, S; Zeitlinger, M	1
Shlaes, DM	1
Hallberg, U; Kahlmeter, G; Tammelin, A; Wiklund, S	1
Fluit, AC; Milatovic, D; Schmitz, FJ; Verhoef, J	1
Citron, DM; Fernandez, HT; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA	1
Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E	1
Adeyi, B; Fernandez, A; Geib, J; Hassett, JM; Teppler, H; Woods, GL; Yellin, AE	1
Citron, DM; Goldstein, EJ; Motyl, M; Pelak, BA; Teppler, H; Woods, GL	1
Behra-Miellet, J; Dubreuil, L; Jumas-Bilak, E	1
Friedland, I; Majumdar, A; Mixson, LA; Motyl, M; Woods, GL	1
Cunha, BA	1
Biedenbach, DJ; Jones, RN; Mathai, D; Rhomberg, PR	1
Blandino, G; Caccamo, F; Milazzo, I; Musumeci, R; Nicoletti, G; Speciale, A	1
Gesser, R; McCarroll, K; Tellado, J; Teppler, H; Woods, GL	1
Jamieson, CE; Lambert, PA; Simpson, IN	1
Alefelder, M; Arvis, P; Berg, O; Gehanno, P; Leiberman, A; Martinkenas, JL; Nikolaidis, P; Reimnitz, P; Siegert, R	1
Antoniadou-Vyza, E; Athanassiou, G; Lada-Chitiroglou, E; Michaleas, S; Tsitsa, T	1
Cisowska, A; Doroszkiewicz, W; Jankowski, S; Korzekwa, K; Lewczyk, E; Wojnicz, D	1
Livermore, DM; Scott, GM; Sefton, AM	1
Johnson, MM; Piddock, LJ; Webber, MA	1
Curran, M; Perry, C; Simpson, D	1
Karpov, OI; Strekachev, AIu; Zaĭtsev, AA	1
Araj, GF; Samaha-Kfoury, JN	1
Ginsburg, I	1
Aguado-García, JM; Lumbreras-Bermejo, C; Martín-Herrero, JE	1
Meibohm, AR; Teppler, H; Woods, GL	1
Hammond, ML	1
Wexler, HM	1
DiNubile, MJ; Majumdar, AK; Nix, DE	1
Goldstein, EJ; Snydman, DR	1
Gesser, RM; Graham, DR; Meibohm, AR; Roy, S; Solomkin, J; Teppler, H; Woods, GL	1
Friedland, IR; Gesser, RM; Herman, G; Isaacs, R; Meibohm, A; Mistry, G; Teppler, H; Woods, GL	1
Tice, AD	1
Georgopapadakou, N	1
Goldstein, EJ	1
Buynak, JD	1
Azanza, JR; Campanero, MA; García-Quetglas, E; Sádaba, B	1
Abe, T; Bradford, PA; Isoda, T; Mansour, TS; Mihira, A; Murphy, TM; O'Connell, J; Petersen, PJ; Projan, S; Takasake, T; Tardio, L; Ushirogochi, H; Venkatesan, AM; Weiss, WJ; Yang, Y	1
Brink, AJ; Feldman, C; Grolman, DC; Muckart, D; Pretorius, J; Richards, GA; Senekal, M; Sieling, W	1
Biedenbach, DJ; Fritsche, TR; Jones, RN; Sader, HS; Toleman, MA; Walsh, TR	1
Alhambra, A; Alós, JI; Gómez-Garcés, JL; Hernáiz, C	1
Asseray, N; Berthelot, JM; Boutoille, D; Gillard, J; Maugars, Y; Varin, S	1
Behra-Miellet, J; Bryskier, A; Dubreuil, L	1
Bliziotis, IA; Chrysanthopoulou, S; Falagas, ME; Samonis, G; Vardakas, KZ	1
Gordon, A; Jeffery, HE	1
Keating, GM; Perry, CM	1
Alfandari, S; Boussekey, N	1
Ahmed, A; Chua, M; Chun, W; Hsueh, PR; Hussain, Y; Jootar, S; Jun, HX; Lee, DG; Lim, V; Lin, SF; Liu, CY; Liu, YC; Matsumoto, T; Ong, A; Picazo, JJ; Purushotaman, SV; Ranuhardy, D; Reksodiputro, AH; Suwangool, P; Tamura, K; Zhixiang, S	1
DeRyke, CA; Kuti, JL; Lee, SY; Nicolau, DP	1
Batard, E; Caillon, J; Kergueris, MF; Le Conte, P; Moreau, P; Navas, D; Potel, G	1
Grozinsky, S; Leibovici, L; Paul, M; Silbiger, I; Soares-Weiser, K	1
Asperger, W; Chan, CY; Dela Pena, AS; DiNubile, MJ; Giezek, H; Kafka, R; Köckerling, F; Raz, R; Shivaprakash, M; Vrijens, F; Warren, B	1
Karasawa, T; Kuriyama, T; Nakagawa, K; Williams, DW; Yamamoto, E	1
Bliziotis, IA; Falagas, ME; Matthaiou, DK; Peppas, G	1
Babic, M; Bonomo, RA; Hujer, AM	1
Baek, JY; Heo, ST; Ko, KS; Kwon, KT; Lee, JY; Lee, MY; Lee, NY; Oh, WS; Park, S; Peck, KR; Ryu, SY; Song, JH	1
Lode, HM	1
Echols, R; Kowalsky, S; Rosemore, M; Tosiello, R; Upchurch, J	1
Ichiki, K; Ikeuchi, H; Nakajima, K; Takesue, Y; Wada, Y; Yanagi, H	1
Borbone, S; Cascone, C; Mezzatesta, ML; Santagati, M; Stefani, S	1
Geddes, AM; Rolinson, GN	1
Mikamo, H	1
Echols, RM; Hadley, JA; Tillotson, GS; Tosiello, R	1
Durnaá, B; Dzierzanowska, D	1
Burkhardt, O; Derendorf, H; Welte, T	1
Hadley, JA; Pfaller, MA	1
Falagas, ME; Karveli, EA; Matthaiou, DK; Peppas, G	1
Bronze, MS; Cooper, TW; Gibbs, WJ; Greenfield, RA	1
Abramson, MA; Jensen, EH; Namias, N; Solomkin, JS; Tomassini, JE	1
Hoban, DJ; Karlowsky, JA; Rubinstein, E; Schurek, KN; Wiebe, R; Zhanel, GG	1
Abramson, MA; Armstrong, DG; Lipsky, BA; Polis, AB; Sheehan, P; Tice, AD	1
Krueger, WA; Lipman, J; Paratz, E; Paratz, J; Roberts, JA	1
Huang, SS; Lee, N; Lee, SC; See, LC; Shieh, WB; Tsai, MH	1
Dilay, L; Hoban, DJ; Karlowsky, JA; Noreddin, AM; Rubinstein, E; Thomson, K; Wiebe, R; Zhanel, GG	1
Abramson, MA; Hoey, CT; Lipsky, BA; Tice, AD; Turpin, RS; Wu, J	1
Cross, SE; Dalley, AJ; Lipman, J; Roberts, MS; Rudd, M; Venkatesh, B	1
Brink, AJ; Feldman, C; Richards, GA	1
Arrieta, AC; Congeni, BL; Fernsler, D; Gesser, R; Higareda, I; Johnson, J; West, J; Yellin, AE	1
Mouton, JW; Vinks, AA	1
Brown, SD; Critchley, IA; Janjic, N; Tillotson, GS; Traczewski, MM	1
Lister, PD	1
Friberg, O; Källman, J	1
Ishii, Y; Tateda, K; Yamaguchi, K	1
Bradley, JS; Rubino, CM	1
Blandino, G; Fazio, D; Milazzo, I; Pappalardo, S; Pisano, M; Puglisi, S; Speciale, A	1
Acuña, C; Gobernado, M	1
Crank, CW; Gettig, JP; Philbrick, AH	1
Falagas, ME; Karageorgopoulos, DE; Makris, GC; Matthaiou, DK; Peppas, G	1
Clarke, MJ; Edwards, SJ; Emmas, CE; Wordsworth, S	1
Barberán, J; Fariñas, C; García, J; Llinares, P; Mensa, J; Moreno, E; Olaechea, P; Palomar, M; Serrano, R; Torres, M	1
Liu, R; Rao, J; Xing, B	1
Neu, HC	3
Medeiros, AA	1
Grimm, H	1
Labthavikul, P; Neu, HC	1
Blacklock, H; Boesen, E; Corringham, R; Gray, R; Hann, I; Mohiuddin, J; Noone, P; Prentice, HG; Sage, R; Stirling, L	1
Greene, WH	1
Wilber, RB	1
Bint, AJ; Pedler, SJ	1
Craig, W	1
Forbes, M; Kuck, NA; Testa, RT	1
Bidwell, JL; Bywater, MJ; Holt, HA; Reeves, DS	1
Lundberg, C	1
Schreiner, A	1
Hedström, SA	1
Ellis-Pegler, RB	1
Bradnock, K; Leigh, DA; Marriner, JM	1
Bonner, DP; Bush, K; Georgopapadakou, NH; Sykes, RB	1
Basker, MJ	1
Wilkinson, PJ	1
Counts, GW; Turck, M	1
Muytjens, HL; van der Ros-van de Repe, J	1
Bernard, T; Buchanan, TC; Floyd, I; Haddad, RJ; Johnston, R; Longenecker, SL; Macey, TI; Mogabgab, WJ	1
Kienitz, M	1
Hadley, WK; Ohm-Smith, MJ; Sweet, RL	1
Nord, CE; Wilson, SE	1
Singh, N; Yu, VL	1
Araki, H; Hayashi, T; Kitayama, R; Minami, S; Ochiai, H; Watanabe, Y	1
Crémieux, AC; Decré, D; Joly-Guillou, ML; Launay, O	1
Pitout, JD; Sanders, CC; Sanders, WE	1
Abdel-Rahman, SM; Kearns, GL	1
Gal, P; Ransom, JL; Rubino, CM	1
Seifert, H	1
Sábada, B	1
Biedenbach, DJ; Gales, AC; Jones, RN; Lewis, MT; Mathai, D; Yamaguchi, K	1
Kotra, LP; Mobashery, S	1
Akatsuka, K; Chimura, T; Funayama, T; Hayashi, Y; Hirayama, T; Kaneko, N; Morisaki, N; Murayama, K; Numazaki, M; Oda, T; Sato, F	1
Finegold, SM	1
Akalin, HE	1
Bush, K; Mobashery, S	1
Holten, KB; Onusko, EM	1
Bolsoni, AP; Mendes, RE; Roland, RK; Sader, HS; Silbert, S	1
Kot, K; Luczak, M; Meisel-Mikołajczyk, F; Pituch, H; Rokosz, A; Sawicka-Grzelak, A	1
Gniadkowski, M	1
Citron, DM; Fernandez, H; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA	1
Adam, D	2
Dajani, AS	1
Lode, H	1
Auckenthaler, R	1
Ho, DH; LeBlanc, BM; Rolston, KV; Streeter, H	1
Abraham, EP	1
Fukada, S; Kojo, H; Mine, Y; Nishida, M; Nonoyama, S	1
Craig, WA; Ebert, SC	1
Angelescu, M; Benea, E	1
Franciolli, M	1
Kamata, S; Matsunaga, T; Uchida, K	1
Drusano, GL	1
Craig, WA; Ebert, S; Fantin, B; Leggett, JE	1
Graham, JE	1
Rosin, H	1
Acar, JF; Gutmann, L; Kitzis, MD	1
Pechère, JC	1
Hoban, DJ	1
Chin, NX; Neu, HC	1
Cullmann, W; Opferkuch, W	1
Haller, I	1
Sanders, CC; Sanders, WE	2
Bingen, E; Lambert-Zechovsky, N; Lemer, G; Mariani-Kurkdjian, P; Sauzeau, C	1
Turck, M	1
Houben, AW; Philips, JM; Stobberingh, EE; van Boven, CP	1
Kobayashi, T; Mizuguchi, Y; Tanabe, T; Yoshida, S	1
Drlicek, M; Kapfhammer, G; Vetter, N	1
Dejace, P; Klastersky, J	2
Sanders, CC; Watanakunakorn, C	1
Daikos, GL; Jackson, GG; Kathpalia, SB; Lolans, VT; Sharifi, R	1
Bakken, JS; Sanders, CC	1
Allan, JD; Eliopoulos, GM; Moellering, RC	1
Fukumoto, K; Kondo, M; Maekawa, N; Nakanishi, M; Nishino, T; Otsuki, M; Saji, Y; Tanaka, M; Tanino, T; Yoshikawa, T	1
Brändle, HP; Hof, H	1
Appel, KR; Lechner, U; Werner, RG	1
Imada, A; Kondo, M; Kuno, M; Okonogi, K; Yukishige, K	1
Browne, M; Cotton, D; Hathorn, J; Hiemenz, J; Longo, D; McKnight, J; Pizzo, PA; Rubin, M; Skelton, J; Thaler, M	1
Young, LS	1
Nelson, JD	1
Masuda, G; Tomioka, S; Uchida, H	1

Reviews

137 review(s) available for beta-lactams and Bacterial Infections

Article	Year
The Odd Couple(s): An Overview of Beta-Lactam Antibiotics Bearing More Than One Pharmacophoric Group. International journal of molecular sciences, 2021, Jan-09, Volume: 22, Issue:2 Topics: Animals; Anti-Bacterial Agents; Azetidines; Bacteria; Bacterial Infections; beta-Lactams; Calixarenes; Drug Discovery; Humans; Lactams, Macrocyclic	2021
Drugs That Changed Society: History and Current Status of the Early Antibiotics: Salvarsan, Sulfonamides, and β-Lactams. Molecules (Basel, Switzerland), 2021, Oct-07, Volume: 26, Issue:19 Topics: Anti-Bacterial Agents; Arsphenamine; Bacterial Infections; beta-Lactams; Drug Development; Drug Discovery; Humans; Quality of Life; Sulfonamides	2021
Prophylactic antibiotics on patients with cirrhosis and upper gastrointestinal bleeding: A meta-analysis. PloS one, 2022, Volume: 17, Issue:12 Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; beta-Lactams; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Quinolones	2022
Treatment of Bacterial Infections with β-Lactams: Cooperation with Innate Immunity. Infection and immunity, 2023, 02-16, Volume: 91, Issue:2 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Humans; Immunity, Innate	2023
A three-level model for therapeutic drug monitoring of antimicrobials at the site of infection. The Lancet. Infectious diseases, 2023, Volume: 23, Issue:10 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; beta-Lactams; Communicable Diseases; Drug Monitoring; Humans	2023
β-lactam antibiotic versus combined β-lactam antibiotics and single daily dosing regimens of aminoglycosides for treating serious infections: A meta-analysis. International journal of antimicrobial agents, 2020, Volume: 55, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic; Retrospective Studies	2020
[ß-lactam antibiotics resistance in Latin American countries]. Medwave, 2019, Nov-20, Volume: 19, Issue:10 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Latin America	2019
Epidemiology of β-Lactamase-Producing Pathogens. Clinical microbiology reviews, 2020, 03-18, Volume: 33, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; beta-Lactams; Clinical Laboratory Techniques; Drug Resistance, Multiple, Bacterial; Humans; Plasmids	2020
Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2 Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea	2022
Development of Peptides that Inhibit Aminoglycoside-Modifying Enzymes and β-Lactamases for Control of Resistant Bacteria. Current protein & peptide science, 2020, Volume: 21, Issue:10 Topics: Aminoglycosides; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Infections; beta-Lactamases; beta-Lactams; Clavulanic Acid; Drug Design; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kanamycin Kinase; Nucleotidyltransferases; Sulbactam; Tazobactam	2020
β-lactam antibiotics: An overview from a medicinal chemistry perspective. European journal of medicinal chemistry, 2020, Dec-15, Volume: 208 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Chemistry, Pharmaceutical; Humans; Hydrolysis; Models, Chemical; Molecular Structure	2020
Population pharmacokinetic models of first choice beta-lactam antibiotics for severe infections treatment: What antibiotic regimen to prescribe in children? Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2020, Volume: 23 Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Child, Preschool; Dose-Response Relationship, Drug; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Models, Biological; Sepsis; Severity of Illness Index; Shock, Septic; Young Adult	2020
Inhibitors of β-Lactamases. New Life of β-Lactam Antibiotics. Biochemistry. Biokhimiia, 2020, Volume: 85, Issue:11 Topics: Animals; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Humans	2020
Pharmacokinetic/pharmacodynamic target attainment in critically ill renal patients on antimicrobial usage: focus on novel beta-lactams and beta lactams/beta-lactamase inhibitors. Expert review of clinical pharmacology, 2021, Volume: 14, Issue:5 Topics: Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; Critical Illness; Dose-Response Relationship, Drug; Drug Development; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Humans; Kidney Diseases	2021
Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis. The Cochrane database of systematic reviews, 2021, 06-23, Volume: 6 Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Humans; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections	2021
Evolution of diagnostic approaches in betalactam hypersensitivity. Expert review of clinical pharmacology, 2017, Volume: 10, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Hypersensitivity; Humans; Lymphocyte Activation; Nanotechnology; Proteomics	2017
Extended infusion of beta-lactam antibiotics: optimizing therapy in critically-ill patients in the era of antimicrobial resistance. Expert review of anti-infective therapy, 2017, Volume: 15, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Critical Illness; Drug Administration Schedule; Drug Resistance, Bacterial; Humans	2017
Penicillin and Beta-Lactam Hypersensitivity. Immunology and allergy clinics of North America, 2017, Volume: 37, Issue:4 Topics: Allergens; Animals; Bacterial Infections; beta-Lactams; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Penicillins	2017
Inhibitors of metallo-β-lactamases. Current opinion in microbiology, 2017, Volume: 39 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; Disease Models, Animal; Humans	2017
Carbapenems vs. alternative β-lactams for the treatment of nosocomial pneumonia: A systematic review and meta-analysis. International journal of antimicrobial agents, 2018, Volume: 52, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Healthcare-Associated Pneumonia; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Odds Ratio; Pseudomonas aeruginosa; Randomized Controlled Trials as Topic; Risk Factors; Staphylococcus aureus; Survival Analysis; Treatment Outcome	2018
New antimicrobial options for the management of complicated intra-abdominal infections. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019, Volume: 38, Issue:5 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Drug Combinations; Drug Resistance, Microbial; Humans; Intraabdominal Infections	2019
Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence. Expert review of anti-infective therapy, 2013, Volume: 11, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Hospital Costs; Humans; Methicillin-Resistant Staphylococcus aureus	2013
[The different intake modalities of oral antibiotics]. Journal de pharmacie de Belgique, 2012, Issue:3 Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacterial Infections; beta-Lactams; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Intestinal Absorption; Macrolides; Tetracyclines	2012
[Microbiology of diabetic foot infections: role of ertapenem]. Drugs of today (Barcelona, Spain : 1998), 2013, Volume: 49 Suppl A Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Diabetic Foot; Drug Resistance, Bacterial; Ertapenem; Humans; Microbial Sensitivity Tests	2013
Prolonging β-lactam infusion: a review of the rationale and evidence, and guidance for implementation. International journal of antimicrobial agents, 2014, Volume: 43, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Humans; Infusions, Intravenous; Time	2014
Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. The Cochrane database of systematic reviews, 2014, Jan-07, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cause of Death; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Randomized Controlled Trials as Topic	2014
Prolonged infusion versus intermittent boluses of β-lactam antibiotics for treatment of acute infections: a meta-analysis. International journal of antimicrobial agents, 2014, Volume: 43, Issue:5 Topics: Administration, Intravenous; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Humans; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome	2014
Single versus combination intravenous antibiotic therapy for people with cystic fibrosis. The Cochrane database of systematic reviews, 2014, Apr-30, Issue:4 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Humans; Injections, Intravenous; Randomized Controlled Trials as Topic; Respiratory Tract Infections	2014
Extended Spectrum Beta-lactamases: Definition, Classification and Epidemiology. Current issues in molecular biology, 2015, Volume: 17 Topics: Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Global Health; Humans; Risk Factors	2015
β-Lactam/β-lactamase inhibitors versus carbapenems for the treatment of sepsis: systematic review and meta-analysis of randomized controlled trials. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:1 Topics: Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; Clostridioides difficile; Diarrhea; Humans; Randomized Controlled Trials as Topic; Sepsis; Survival Analysis; Treatment Outcome	2015
Inhaled antibiotics beyond aminoglycosides, polymyxins and aztreonam: A systematic review. International journal of antimicrobial agents, 2015, Volume: 45, Issue:3 Topics: Administration, Inhalation; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Bronchiectasis; Cystic Fibrosis; Fosfomycin; Humans; Pneumonia, Ventilator-Associated; Quinolones; Respiratory Tract Infections; Treatment Outcome	2015
[Betalactams in clinical practice]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2015, Volume: 28, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Humans	2015
Administration of parenteral prophylactic beta-lactam antibiotics in 2014: a review. Anesthesia and analgesia, 2015, Volume: 120, Issue:4 Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; beta-Lactams; Biofilms; Humans; Perioperative Care; Skin; Surgical Wound Infection; Time Factors; Tourniquets	2015
New promising β-lactamase inhibitors for clinical use. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:7 Topics: Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Drug Therapy, Combination; Humans	2015
Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for? The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:12 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Drug Monitoring; Humans; Microbial Sensitivity Tests	2015
Assays for therapeutic drug monitoring of β-lactam antibiotics: A structured review. International journal of antimicrobial agents, 2015, Volume: 46, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Monitoring; Humans; Plasma	2015
β-Lactamases: Why and How. Journal of medicinal chemistry, 2016, Sep-22, Volume: 59, Issue:18 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; beta-Lactams; Catalytic Domain; Drug Resistance, Bacterial; Humans; Models, Molecular; Serine-Type D-Ala-D-Ala Carboxypeptidase	2016
Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory. Clinical microbiology reviews, 2016, Volume: 29, Issue:4 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Humans; Infusions, Intravenous; Treatment Outcome	2016
[Old and new antibiotics for therapy of multidrug resistant bacteria]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2016, Volume: 29 Suppl 1 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Resistance, Multiple, Bacterial; Humans	2016
Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis. The Cochrane database of systematic reviews, 2016, 12-01, Volume: 12 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Humans; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections	2016
The challenge of multidrug resistance: the treatment of gram-negative rod infections. Shock (Augusta, Ga.), 2008, Volume: 30 Suppl 1 Topics: Acinetobacter; Bacterial Infections; beta-Lactamases; beta-Lactams; Clinical Trials as Topic; Drug Resistance, Multiple; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Ertapenem; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Minocycline; Polymyxins; Pseudomonas aeruginosa; Sulbactam; Tigecycline	2008
New agents in development for the treatment of bacterial infections. Current opinion in pharmacology, 2008, Volume: 8, Issue:5 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Glycopeptides; Humans; Macrolides; Oxazolidinones; Quinolones	2008
[Beta-lactam antibiotics]. Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:2 Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; Bacteriolysis; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cell Wall; Cross Infection; Drug Hypersensitivity; Drug Resistance, Multiple, Bacterial; Gastrointestinal Diseases; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic; Organ Specificity; Spain	2009
Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update. Critical reviews in microbiology, 2009, Volume: 35, Issue:2 Topics: Acinetobacter; Bacterial Infections; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactams; Enterobacteriaceae; Enzyme Inhibitors; Humans	2009
beta-Lactamases- the Threat Renews. Current protein & peptide science, 2009, Volume: 10, Issue:5 Topics: Bacterial Infections; beta-Lactamases; beta-Lactams; Drug Design; Drug Resistance, Bacterial; Escherichia coli; Global Health; Humans; Microbial Sensitivity Tests; Models, Chemical; Penicillins; Staphylococcus aureus	2009
Three decades of the class A beta-lactamase acyl-enzyme. Current protein & peptide science, 2009, Volume: 10, Issue:5 Topics: Bacterial Infections; beta-Lactamases; beta-Lactams; Binding Sites; Catalysis; Catalytic Domain; Chemistry, Pharmaceutical; Crystallography, X-Ray; Humans; Hydrolysis; Models, Chemical; Penicillins; Protein Conformation; Serine; Spectrophotometry, Infrared	2009
Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Female; Humans; Male; Teicoplanin; Vancomycin	2009
Infections of the upper respiratory tract, head, and neck. The role of anaerobic bacteria. Postgraduate medicine, 2000, Volume: 108, Issue:7 Suppl Co Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Fluoroquinolones; Humans; Respiratory Tract Infections; Risk Factors; Tetracycline	2000
Urinary tract infections. Current approaches, future directions. Postgraduate medicine, 2000, Volume: 108, Issue:7 Suppl Pr Topics: Age Factors; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacterial Infections; beta-Lactams; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Male; Pregnancy; Prevalence; Recurrence; Sex Factors; Urinary Tract Infections	2000
Newer beta-lactam antibiotics: doripenem, ceftobiprole, ceftaroline, and cefepime. Infectious disease clinics of North America, 2009, Volume: 23, Issue:4 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Humans	2009
Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials. BMC infectious diseases, 2009, Dec-02, Volume: 9 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Penicillanic Acid; Piperacillin; Randomized Controlled Trials as Topic; Tazobactam; Treatment Outcome	2009
New β-lactam antibiotics and β-lactamase inhibitors. Expert opinion on therapeutic patents, 2010, Volume: 20, Issue:10 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gram-Negative Bacteria; Humans	2010
The future of the β-lactams. Current opinion in microbiology, 2010, Volume: 13, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Monobactams	2010
β-Lactam and glycopeptide antibiotics: first and last line of defense? Trends in biotechnology, 2010, Volume: 28, Issue:12 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Cell Wall; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Glycopeptides; Humans	2010
Conclusions. Role of the oral Beta-lactams in the treatment of exacerbations of chronic bronchitis: critical analysis and therapeutics recommendations. Journal of chemotherapy (Florence, Italy), 2010, Volume: 22 Suppl 1 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Bronchitis, Chronic; Humans; Practice Guidelines as Topic; Treatment Outcome	2010
Clinical implications of β-lactam-aminoglycoside synergism: systematic review of randomised trials. International journal of antimicrobial agents, 2011, Volume: 37, Issue:6 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Synergism; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic; Treatment Outcome	2011
Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics. Minerva anestesiologica, 2012, Volume: 78, Issue:1 Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Critical Care; Critical Illness; Cystic Fibrosis; Fever; Humans; Infusions, Intravenous; Length of Stay; Leukocyte Count; Neoplasms; Respiration, Artificial; Treatment Outcome	2012
Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors. Current opinion in microbiology, 2011, Volume: 14, Issue:5 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; Clinical Trials as Topic; Drug Discovery; Enzyme Inhibitors; Humans	2011
[Antibiotics: new and old drugs, rational prescription]. Deutsche medizinische Wochenschrift (1946), 2012, Volume: 137, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Biological Availability; Cephalosporins; Colistin; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Half-Life; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Practice Patterns, Physicians'	2012
New β-lactam-β-lactamase inhibitor combinations in clinical development. Annals of the New York Academy of Sciences, 2013, Volume: 1277 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; Clinical Trials as Topic; Humans; Microbial Sensitivity Tests	2013
Ertapenem. A review of its microbiologic, pharmacokinetic and clinical aspects. Drugs of today (Barcelona, Spain : 1998), 2002, Volume: 38, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Child; Drug Interactions; Ertapenem; Humans; Infusions, Intravenous; Lactams	2002
Properties and potential of ertapenem. The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:3 Topics: Bacteria; Bacterial Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Drug Resistance, Bacterial; Ertapenem; Half-Life; Humans; Lactams	2003
Ertapenem: a review of its use in the management of bacterial infections. Drugs, 2003, Volume: 63, Issue:17 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Lactams	2003
[New approaches to antibacterial therapy of infections in the surgical practice]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003, Volume: 48, Issue:5 Topics: Abdominal Abscess; Aza Compounds; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Cross Infection; Ertapenem; Fluoroquinolones; Humans; Lactams; Moxifloxacin; Quinolines; Randomized Controlled Trials as Topic; Surgical Wound Infection	2003
Recent developments in beta lactamases and extended spectrum beta lactamases. BMJ (Clinical research ed.), 2003, Nov-22, Volume: 327, Issue:7425 Topics: Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Drug Resistance, Bacterial; Humans; Infection Control	2003
[Bacterial resistance and pharmacodynamics as the basis for prescribing antibiotics in respiratory infections]. Enfermedades infecciosas y microbiologia clinica, 2004, Volume: 22, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; beta-Lactams; Clavulanic Acid; Dose-Response Relationship, Drug; Drug Resistance; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Haemophilus influenzae; Humans; Macrolides; Microbial Sensitivity Tests; Respiratory Tract Infections; Spain; Streptococcus pneumoniae	2004
Ertapenem: a Group 1 carbapenem with distinct antibacterial and pharmacological properties. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Carbapenems; Community-Acquired Infections; Ertapenem; Humans; Lactams	2004
In vitro activity of ertapenem: review of recent studies. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lactams; Microbial Sensitivity Tests	2004
Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Renal Insufficiency	2004
Safety and tolerability of ertapenem. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Ceftriaxone; Clinical Trials as Topic; Community-Acquired Infections; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Randomized Controlled Trials as Topic	2004
The discovery and development of modified penicillin- and cephalosporin-derived beta-lactamase inhibitors. Current medicinal chemistry, 2004, Volume: 11, Issue:14 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Enzyme Inhibitors; Humans	2004
Appropriate use of the carbapenems. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2004, Volume: 94, Issue:10 Pt 2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cilastatin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Patient Selection; Pneumonia, Bacterial; Practice Patterns, Physicians'; Protease Inhibitors; South Africa; Surgical Wound Infection; Thienamycins; Urinary Tract Infections	2004
Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jul-15, Volume: 41, Issue:2 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Odds Ratio; Randomized Controlled Trials as Topic; Superinfection; Treatment Failure	2005
Antibiotic regimens for suspected late onset sepsis in newborn infants. The Cochrane database of systematic reviews, 2005, Jul-20, Issue:3 Topics: Aminoglycosides; Bacterial Infections; beta-Lactams; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Sepsis; Time Factors	2005
Ertapenem: a review of its use in the treatment of bacterial infections. Drugs, 2005, Volume: 65, Issue:15 Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Child, Preschool; Drug Resistance, Bacterial; Ertapenem; Humans; Infant	2005
Optimising dosing strategies of antibacterials utilising pharmacodynamic principles: impact on the development of resistance. Drugs, 2006, Volume: 66, Issue:1 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Streptococcus pneumoniae	2006
Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. The Cochrane database of systematic reviews, 2006, Jan-25, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cause of Death; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Randomized Controlled Trials as Topic	2006
Ciprofloxacin/metronidazole versus beta-lactam-based treatment of intra-abdominal infections: a meta-analysis of comparative trials. International journal of antimicrobial agents, 2006, Volume: 28, Issue:3 Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ciprofloxacin; Drug Therapy, Combination; Humans; Metronidazole; PubMed; Randomized Controlled Trials as Topic	2006
What's new in antibiotic resistance? Focus on beta-lactamases. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2006, Volume: 9, Issue:3 Topics: Animals; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Plasmids	2006
[Uses in in ambulatory and stationary situations. Clinical indications for beta lactams]. Pharmazie in unserer Zeit, 2006, Volume: 35, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Humans	2006
The 50th anniversary of the discovery of 6-aminopenicillanic acid (6-APA). International journal of antimicrobial agents, 2007, Volume: 29, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Humans; Hydrolysis; Penicillanic Acid; Penicillins; Thienamycins	2007
[Antibiotic therapy for pregnant patients]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2006, Nov-10, Volume: 95, Issue:11 Topics: Abnormalities, Drug-Induced; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Female; Humans; Informed Consent; Macrolides; Maternal-Fetal Exchange; Milk, Human; Patient Education as Topic; Placenta; Pregnancy; Pregnancy Complications, Infectious	2006
Faropenem medoxomil: a treatment option in acute bacterial rhinosinusitis. Expert review of anti-infective therapy, 2006, Volume: 4, Issue:6 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Sinusitis; Streptococcus pneumoniae; United States	2006
[Infection in neutropenic cancer patients--etiology, microbiological diagnostics, treatment]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2006, Volume: 59, Issue:7-8 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Drug Combinations; Female; Fever; Humans; Male; Microbial Sensitivity Tests; Neoplasms; Neutropenia	2006
Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice. Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Critical Illness; Drug Interactions; Drug Resistance, Bacterial; Endometritis; Ertapenem; Female; Humans; Peritonitis; Protein Binding; Renal Insufficiency; Surgical Wound Infection; Urinary Tract Infections	2007
Oral beta-lactams in the treatment of acute bacterial rhinosinusitis. Diagnostic microbiology and infectious disease, 2007, Volume: 57, Issue:3 Suppl Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Humans; Practice Guidelines as Topic; Rhinitis; Sinusitis	2007
Meta-analysis: randomized controlled trials of clindamycin/aminoglycoside vs. beta-lactam monotherapy for the treatment of intra-abdominal infections. Alimentary pharmacology & therapeutics, 2007, Mar-01, Volume: 25, Issue:5 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Digestive System Diseases; Humans; Randomized Controlled Trials as Topic; Treatment Outcome	2007
Part V. Other beta-lactam antimicrobials. The Journal of the Oklahoma State Medical Association, 2007, Volume: 100, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Humans; Monobactams	2007
Faropenem: review of a new oral penem. Expert review of anti-infective therapy, 2007, Volume: 5, Issue:2 Topics: Administration, Oral; Animals; Bacterial Infections; beta-Lactams; Humans	2007
Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role. International journal of antimicrobial agents, 2007, Volume: 30, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Humans; Infusions, Intravenous	2007
Comparative review of the carbapenems. Drugs, 2007, Volume: 67, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Doripenem; Ertapenem; Humans; Imipenem; Meropenem; Thienamycins	2007
Continuous infusion of beta-lactams. Current opinion in critical care, 2007, Volume: 13, Issue:5 Topics: Animals; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Stability; Humans; Infusions, Intravenous; Intensive Care Units; Microbial Sensitivity Tests	2007
Carbapenems in the USA: focus on doripenem. Expert review of anti-infective therapy, 2007, Volume: 5, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Doripenem; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Structure-Activity Relationship; Thienamycins; United States	2007
Antibiotic prophylaxis in cardiac surgery--general principles. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2007, Volume: 115, Issue:9 Topics: Antibiotic Prophylaxis; Bacterial Infections; beta-Lactams; Cardiac Surgical Procedures; Humans; Surgical Wound Infection	2007
Optimizing therapy with antibacterial agents: use of pharmacokinetic-pharmacodynamic principles in pediatrics. Paediatric drugs, 2007, Volume: 9, Issue:6 Topics: Aminoglycosides; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; beta-Lactams; Child; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Predictive Value of Tests	2007
[Ertapenem]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2007, Volume: 20, Issue:3 Topics: Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Cell Wall; Child; Diabetes Complications; Double-Blind Method; Drug Costs; Drug Synergism; Ertapenem; Female; Humans; Male; Obesity; Pregnancy; Randomized Controlled Trials as Topic; Tissue Distribution	2007
Faropenem medoxomil. The Annals of pharmacotherapy, 2008, Volume: 42, Issue:1 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Humans; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic; Time Factors	2008
Meta-analysis: ertapenem for complicated intra-abdominal infections. Alimentary pharmacology & therapeutics, 2008, Volume: 27, Issue:10 Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Randomized Controlled Trials as Topic; Treatment Outcome	2008
Faropenem medoxomil: A0026, BAY 56-6854, BAY 566854, faropenem daloxate, SUN 208, SUN A0026. Drugs in R&D, 2008, Volume: 9, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Drug Interactions; Humans; Prodrugs	2008
Carbapenems versus other beta-lactams in treating severe infections in intensive care: a systematic review of randomised controlled trials. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2008, Volume: 27, Issue:7 Topics: Bacterial Infections; beta-Lactams; Critical Care; Humans; Neutropenia; Randomized Controlled Trials as Topic; Treatment Outcome	2008
Novel beta-lactam antibiotics derivatives: their new applications as gene reporters, antitumor prodrugs and enzyme inhibitors. Mini reviews in medicinal chemistry, 2008, Volume: 8, Issue:5 Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Bacterial Infections; beta-Lactams; Enzyme Inhibitors; Genes, Reporter; Humans; Models, Molecular; Molecular Probes; Molecular Structure; Neoplasms; Prodrugs; Stereoisomerism	2008
Changing patterns of hospital infections: implications for therapy. Changing mechanisms of bacterial resistance. The American journal of medicine, 1984, Jul-31, Volume: 77, Issue:1B Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; beta-Lactams; Chromosomes, Bacterial; Cross Infection; DNA Transposable Elements; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Protein Binding; R Factors; Receptors, Drug	1984
Beta-lactamases. British medical bulletin, 1984, Volume: 40, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; beta-Lactams; DNA Transposable Elements; Drug Resistance, Microbial; Genes, Bacterial; Humans; Plasmids	1984
The role of the newer beta-lactam antibiotics in the treatment of infection in compromised hosts. Bulletin of the New York Academy of Medicine, 1984, Volume: 60, Issue:4 Topics: Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Humans; Immunosuppression Therapy; Neoplasms; Neutropenia; Sepsis	1984
Beta-lactam therapy of osteomyelitis and septic arthritis. Scandinavian journal of infectious diseases. Supplementum, 1984, Volume: 42 Topics: Adolescent; Adult; Anti-Bacterial Agents; Arthritis, Infectious; Bacterial Infections; beta-Lactams; Child, Preschool; Humans; Infant, Newborn; Kinetics; Osteomyelitis; Safety	1984
Pharmacokinetic and experimental data on beta-lactam antibiotics in the treatment of patients. European journal of clinical microbiology, 1984, Volume: 3, Issue:6 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Escherichia coli; Half-Life; Humans; Kinetics; Klebsiella pneumoniae; Mice; Pseudomonas aeruginosa; Streptococcus pneumoniae	1984
beta-Lactam antibiotics in the newborn. The Journal of antimicrobial chemotherapy, 1982, Volume: 9 Suppl B Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Humans; Infant, Newborn; Infant, Newborn, Diseases	1982
Clinical trials of extended spectrum penicillin/beta-lactamase inhibitors in the treatment of intra-abdominal infections. European and North American experience. American journal of surgery, 1995, Volume: 169, Issue:5A Suppl Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; Canada; Clinical Trials as Topic; Europe; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Treatment Outcome; United States	1995
[Beta-lactamase inhibitors]. Presse medicale (Paris, France : 1983), 1997, Mar-29, Volume: 26, Issue:10 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; Drug Therapy, Combination; Enzyme Inhibitors; Humans	1997
Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli. The American journal of medicine, 1997, Volume: 103, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans	1997
The beta-lactamase inhibitors: clinical pharmacology and rational application to combination antibiotic therapy. The Pediatric infectious disease journal, 1998, Volume: 17, Issue:12 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Child, Preschool; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Infant; Male	1998
A review of the pharmacokinetic and pharmacodynamic characteristics of beta-lactam/beta-lactamase inhibitor combination antibiotics in premature infants. The Pediatric infectious disease journal, 1998, Volume: 17, Issue:12 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Blood-Brain Barrier; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Infant, Premature; Male; Treatment Outcome	1998
Mechanistic and clinical aspects of beta-lactam antibiotics and beta-lactamases. Archivum immunologiae et therapiae experimentalis, 1999, Volume: 47, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Enzyme Inhibitors; Humans	1999
In vitro efficacy of beta-lactam/beta-lactamase inhibitor combinations against bacteria involved in mixed infections. International journal of antimicrobial agents, 1999, Volume: 12 Suppl 1 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests	1999
The role of beta-lactam/beta-lactamase inhibitors in the management of mixed infections. International journal of antimicrobial agents, 1999, Volume: 12 Suppl 1 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Brain Abscess; Diabetic Foot; Drug Therapy, Combination; Endometritis; Enzyme Inhibitors; Female; Humans; Peritonitis; Surgical Wound Infection	1999
How beta-lactamases have driven pharmaceutical drug discovery. From mechanistic knowledge to clinical circumvention. Advances in experimental medicine and biology, 1998, Volume: 456 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Design; Humans	1998
Appropriate prescribing of oral beta-lactam antibiotics. American family physician, 2000, Aug-01, Volume: 62, Issue:3 Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Prescriptions; Humans	2000
Evolution and epidemiology of extended-spectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2001, Volume: 7, Issue:11 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Evolution, Molecular; Humans	2001
Beta-lactam/beta-lactamase inhibitor combinations in empiric management of pediatric infections. The Journal of international medical research, 2002, Volume: 30 Suppl 1 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Child; Community-Acquired Infections; Drug Tolerance; Enzyme Inhibitors; Humans; Patient Compliance; Safety	2002
Beta-lactam resistance: clinical implications for pediatric patients. The Journal of international medical research, 2002, Volume: 30 Suppl 1 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Child; Community-Acquired Infections; Cross Infection; Humans; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus	2002
Community-acquired lower respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors. International journal of clinical practice. Supplement, 2002, Issue:125 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Humans; Respiratory Tract Infections	2002
beta-Lactam antibiotics and related substances. The Japanese journal of antibiotics, 1977, Volume: 30 Suppl Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Carboxypeptidases; Cephalosporinase; Cephalosporins; Drug Synergism; Humans; Hydrolases; Penicillanic Acid; Penicillin Resistance; Penicillinase; Penicillins; Staphylococcus; Streptomyces; Structure-Activity Relationship	1977
Continuous infusion of beta-lactam antibiotics. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:12 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Disease Models, Animal; Humans; Infusions, Intravenous	1992
[The place of old and new beta-lactams in the therapy of infection]. Medicina interna (Bucharest, Romania : 1991), 1991, Volume: 43, Issue:1-2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Humans	1991
[Beta-lactam/beta-lactamase inhibitor combinations for oral administration]. Schweizerische medizinische Wochenschrift, 1991, Sep-28, Volume: 121, Issue:39 Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Drug Combinations; Drug Synergism; Humans	1991
Human pharmacodynamics of beta-lactams, aminoglycosides and their combination. Scandinavian journal of infectious diseases. Supplementum, 1990, Volume: 74 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Therapy, Combination; Humans	1990
Infectious morbidity in gynecologic oncology. The Journal of reproductive medicine, 1990, Volume: 35, Issue:3 Suppl Topics: Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; Female; Genital Neoplasms, Female; Humans	1990
[The beta-lactam antibiotics]. Der Internist, 1989, Volume: 30, Issue:1 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Humans	1989
The incidence of beta-lactamase-producing pathogens. APMIS. Supplementum, 1989, Volume: 5 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; beta-Lactams; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Humans	1989
Emergence of resistance in gram-negative bacilli during beta-lactam therapy: a challenge for the future. European journal of cancer & clinical oncology, 1989, Volume: 25 Suppl 2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans	1989
Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications. The Journal of infectious diseases, 1985, Volume: 151, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Cell Membrane Permeability; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Induction; Humans; Microbial Sensitivity Tests; Mutation; Porins	1985
The role of beta-lactamase inhibitors in chemotherapy. Pharmacology & therapeutics, 1985, Volume: 30, Issue:1 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Gram-Negative Bacteria; Humans; Lactams; Penicillanic Acid; Sulfones	1985
Clinical application of the newer beta-lactam antibiotics. The Journal of antimicrobial chemotherapy, 1988, Volume: 22 Suppl A Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Resistance, Microbial; Humans; Structure-Activity Relationship	1988
Clinical importance of inducible beta-lactamases in gram-negative bacteria. European journal of clinical microbiology, 1987, Volume: 6, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Enzyme Induction; Gram-Negative Bacteria; Humans	1987
Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods. European journal of clinical microbiology, 1987, Volume: 6, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Enzyme Induction; Enzyme Repression; Gram-Negative Bacteria; Humans	1987
[A comparative review of combination therapy: 2 beta-lactams versus beta-lactam plus aminoglycoside]. Infection, 1987, Volume: 15 Suppl 4 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Drug Therapy, Combination; Humans; Opportunistic Infections	1987
Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside. The American journal of medicine, 1986, Jun-30, Volume: 80, Issue:6B Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cellulitis; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Neoplasms; Neutropenia; Pneumonia; Pseudomonas Infections; Sepsis; Urinary Tract Infections	1986

Trials

19 trial(s) available for beta-lactams and Bacterial Infections

Article	Year
Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2 Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea	2022
Ertapenem versus piperacillin/tazobactam for diabetic foot infections in China: a Phase 3, multicentre, randomized, double-blind, active-controlled, non-inferiority trial. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; China; Diabetic Foot; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Ertapenem; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Young Adult	2016
Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial: A Randomized Clinical Trial. JAMA surgery, 2017, 03-01, Volume: 152, Issue:3 Topics: Abdominal Abscess; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; beta-Lactams; Double-Blind Method; Ertapenem; Female; Gram-Negative Bacteria; Humans; Intention to Treat Analysis; Male; Middle Aged; Peritonitis; Tetracyclines; Treatment Outcome; Young Adult	2017
Infection after elective colorectal surgery: bacteriological analysis of failures in a randomized trial of cefotetan vs. ertapenem prophylaxis. Surgical infections, 2009, Volume: 10, Issue:2 Topics: Antibiotic Prophylaxis; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Cefotetan; Colon; Elective Surgical Procedures; Ertapenem; Humans; Microbial Sensitivity Tests; Rectum; Surgical Wound Infection; Treatment Failure	2009
A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin-Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapene BMC gastroenterology, 2011, Apr-18, Volume: 11 Topics: Abdomen; Adult; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Protocols; Community-Acquired Infections; Drug Therapy, Combination; Ertapenem; Humans; Peritonitis; Sulbactam	2011
Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults. International journal of antimicrobial agents, 2002, Volume: 20, Issue:3 Topics: Abdomen; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; beta-Lactams; Ceftriaxone; Double-Blind Method; Drug Therapy, Combination; Ertapenem; Female; Humans; Injections, Intravenous; Lactams; Male; Metronidazole; Middle Aged	2002
Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections. Surgical infections, 2002,Winter, Volume: 3, Issue:4 Topics: Abdomen; Adult; Aged; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Pelvic Infection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Skin Diseases, Bacterial; Surgical Wound Infection	2002
Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2003, Volume: 260, Issue:4 Topics: Acute Disease; Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefuroxime; Double-Blind Method; Female; Humans; Lactams; Male; Maxillary Sinusitis; Middle Aged; Prospective Studies; Treatment Outcome	2003
Management of complicated appendicitis and comparison of outcome with other primary sites of intra-abdominal infection: results of a trial comparing ertapenem and piperacillin-tazobactam. Journal of chemotherapy (Florence, Italy), 2004, Volume: 16, Issue:1 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; beta-Lactams; Colonic Diseases; Demography; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Severity of Illness Index	2004
Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Abdomen; Adolescent; Adult; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Pelvic Infection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Skin Diseases, Bacterial; Treatment Outcome	2004
Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2006, Volume: 10, Issue:4 Topics: Abdomen; Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Diarrhea; Ertapenem; Escherichia coli Infections; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome	2006
Randomized double-blind study comparing 7- and 10-day regimens of faropenem medoxomil with a 10-day cefuroxime axetil regimen for treatment of acute bacterial sinusitis. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2006, Volume: 135, Issue:4 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefuroxime; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Prospective Studies; Sinusitis; Time Factors	2006
Randomized, multicenter, double-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intra-abdominal infections in hospitalized adults. Surgical infections, 2007, Volume: 8, Issue:1 Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacterial Infections; Bacteroides; beta-Lactams; Double-Blind Method; Ertapenem; Escherichia coli; Female; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination	2007
Ertapenem or ticarcillin/clavulanate for the treatment of intra-abdominal infections or acute pelvic infections in pediatric patients. American journal of surgery, 2007, Volume: 194, Issue:3 Topics: Abdominal Cavity; Acute Disease; Adolescent; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Child, Preschool; Clavulanic Acids; Ertapenem; Female; Humans; Male; Pelvis; Prospective Studies; Ticarcillin	2007
The results of a randomized trial of empirical antibiotic treatment in febrile neutropenic patients with four beta-lactam/aminoglycoside combinations. The Journal of antimicrobial chemotherapy, 1983, Volume: 11 Suppl C Topics: Agranulocytosis; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Neutropenia; Random Allocation	1983
[Clinical studies of faropenem in the field of obstetrics and gynecology]. The Japanese journal of antibiotics, 1999, Volume: 52, Issue:7 Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cystitis; Female; Genital Diseases, Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Lactams; Mastitis; Middle Aged; Pelvic Inflammatory Disease; Uterine Cervicitis; Uterine Diseases	1999
Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside. The American journal of medicine, 1986, Jun-30, Volume: 80, Issue:6B Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cellulitis; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Neoplasms; Neutropenia; Pneumonia; Pseudomonas Infections; Sepsis; Urinary Tract Infections	1986
Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora. The American journal of medicine, 1987, Apr-27, Volume: 82, Issue:4A Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ciprofloxacin; Clinical Trials as Topic; Drug Resistance, Microbial; Feces; Female; Gram-Negative Aerobic Bacteria; Humans; Intestines; Male; Middle Aged; Urinary Tract Infections	1987
New beta-lactam antibiotics in granulocytopenic patients. New options and new questions. The American journal of medicine, 1985, Aug-09, Volume: 79, Issue:2A Topics: Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Drug Therapy, Combination; Humans	1985

Other Studies

158 other study(ies) available for beta-lactams and Bacterial Infections

Article	Year
Early Antibiotic Discontinuation or De-escalation in High-Risk Patients With AML With Febrile Neutropenia and Prolonged Neutropenia. Journal of the National Comprehensive Cancer Network : JNCCN, 2022, 02-04, Volume: 20, Issue:3 Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Febrile Neutropenia; Humans; Leukemia, Myeloid, Acute	2022
Potential risks of treating bacterial infections with a combination of β-lactam and aminoglycoside antibiotics: A systematic quantification of antibiotic interactions in E. coli blood stream infection isolates. EBioMedicine, 2022, Volume: 78 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; beta-Lactams; Drug Synergism; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests	2022
Comprehensive investigation of antibiotic resistance gene content in cfiA-harboring Bacteroides fragilis isolates of human and animal origins by whole genome sequencing. International journal of medical microbiology : IJMM, 2022, Volume: 312, Issue:6 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; beta-Lactams; Chickens; Dogs; Drug Resistance, Microbial; Humans; Linezolid; Macrolides; Metronidazole; Microbial Sensitivity Tests; Phylogeny; Sulfonamides; Swine; Tetracyclines; Whole Genome Sequencing	2022
Incidence, clinical characteristics, risk factors and outcomes of patients with mixed Candida/bacterial bloodstream infections: a retrospective study. Annals of clinical microbiology and antimicrobials, 2022, Nov-01, Volume: 21, Issue:1 Topics: Adult; Bacteria; Bacterial Infections; beta-Lactams; Candida; Candida albicans; Candidemia; Candidiasis; Coinfection; Humans; Incidence; Klebsiella pneumoniae; Retrospective Studies; Risk Factors	2022
Impact of Beta-lactam Allergy on Treatment of Outpatient Infections. Clinical therapeutics, 2019, Volume: 41, Issue:12 Topics: Ambulatory Care; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Drug Hypersensitivity; Humans; Inappropriate Prescribing; Retrospective Studies	2019
The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 11-13, Volume: 69, Issue:Suppl 7 Topics: Bacterial Infections; beta-Lactams; Cefiderocol; Cephalosporins; Drug Design; Drug Development; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Iron; Models, Molecular; Siderophores	2019
Intra-abdominal infections: the role of different classifications on the selection of the best antibiotic treatment. BMC infectious diseases, 2019, Nov-21, Volume: 19, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Cephalosporins; Female; Humans; Intraabdominal Infections; Male; Metronidazole; Middle Aged; Retrospective Studies	2019
Pharmacokinetic aspects of beta-lactam antibiotic therapy in intensive care unit patients: A one-center experience with TDM. Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti, 2020,Winter, Volume: 69, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Critical Illness; Czech Republic; Drug Monitoring; Humans; Intensive Care Units	2020
Association Between the Prothrombin Time-International Normalized Ratio and Concomitant Use of Antibiotics in Warfarin Users: Focus on Type of Antibiotic and Susceptibility of The Annals of pharmacotherapy, 2021, Volume: 55, Issue:2 Topics: Aged; Anti-Bacterial Agents; Anticoagulants; Bacterial Infections; Bacteroides fragilis; beta-Lactams; Blood Coagulation; Cohort Studies; Drug Interactions; Female; Fluoroquinolones; Hemorrhage; Humans; International Normalized Ratio; Longitudinal Studies; Male; Middle Aged; Prothrombin Time; Warfarin	2021
4-( Biomolecules, 2020, 07-23, Volume: 10, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Biocatalysis; Carbapenems; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Thiones; Triazoles	2020
Chemically Induced Cell Wall Stapling in Bacteria. Cell chemical biology, 2021, 02-18, Volume: 28, Issue:2 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Cell Wall; Cross-Linking Reagents; Escherichia coli; Humans; Peptides	2021
Long-Term Impact of Suppressive Antibiotic Therapy on Intestinal Microbiota. Genes, 2020, 12-30, Volume: 12, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bacterial Infections; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Escherichia coli; Feces; Female; Fluoroquinolones; Gastrointestinal Microbiome; Glycopeptides; Humans; Macrolides; Male; Microbial Sensitivity Tests; Prospective Studies; Prosthesis-Related Infections; RNA, Ribosomal, 16S; Staphylococcus aureus	2020
Clinical and pharmacokinetic/dynamic outcomes of prolonged infusions of beta-lactam antimicrobials: An overview of systematic reviews. PloS one, 2021, Volume: 16, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Humans; Infusions, Intravenous; Systematic Reviews as Topic; Treatment Outcome	2021
Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective? Expert review of anti-infective therapy, 2017, Volume: 15, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans	2017
Too much of a good thing: a retrospective study of β-lactam concentration-toxicity relationships. The Journal of antimicrobial chemotherapy, 2017, 10-01, Volume: 72, Issue:10 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clostridium Infections; Cohort Studies; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Floxacillin; Humans; Incidence; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neurotoxicity Syndromes; Piperacillin; Retrospective Studies; Thienamycins	2017
Considerable variation of trough β-lactam concentrations in older adults hospitalized with infection-a prospective observational study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:3 Topics: Aged; Aged, 80 and over; Analysis of Variance; Bacterial Infections; beta-Lactams; Cefotaxime; Drug Monitoring; Female; Humans; Length of Stay; Male; Meropenem; Patient Readmission; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sepsis; Sweden; Thienamycins	2018
Continuous beta-lactam intravenous antibiotic infusions for outpatient parenteral antimicrobial therapy. International journal of antimicrobial agents, 2018, Volume: 52, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Costs and Cost Analysis; Home Infusion Therapy; Humans; Infusions, Intravenous; Outpatients; Penicillins; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; United Kingdom	2018
In Silico Design and Enantioselective Synthesis of Functionalized Monocyclic 3-Amino-1-carboxymethyl-β-lactams as Inhibitors of Penicillin-Binding Proteins of Resistant Bacteria. Chemistry (Weinheim an der Bergstrasse, Germany), 2018, Oct-12, Volume: 24, Issue:57 Topics: Amination; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Computer Simulation; Computer-Aided Design; Drug Design; Drug Resistance, Bacterial; Enterococcus faecium; Escherichia coli; Escherichia coli Infections; Gram-Positive Bacterial Infections; Humans; Molecular Docking Simulation; Penicillin-Binding Proteins	2018
Profound underdosing of β-lactams in patients with sickle-cell disease. The Journal of antimicrobial chemotherapy, 2018, 11-01, Volume: 73, Issue:11 Topics: Amoxicillin; Anemia, Sickle Cell; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefotaxime; Humans; Prospective Studies	2018
Modeling Ertapenem: the impact of body mass index on distribution of the antibiotic in the body. Mathematical biosciences and engineering : MBE, 2019, 01-15, Volume: 16, Issue:2 Topics: Algorithms; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Body Mass Index; Body Weight; Carbapenems; Computer Simulation; Drug Administration Schedule; Ertapenem; Female; Humans; Male; Models, Theoretical; Obesity; Thinness	2019
Prolonged infusion with β-lactam antibiotics for treatment of infection caused by non-susceptible bacteria: a study protocol for a systemic review and meta-analysis. BMJ open, 2019, 05-22, Volume: 9, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Humans; Infusions, Intravenous; Meta-Analysis as Topic; Systematic Reviews as Topic	2019
Unusual drug reaction between valproate sodium and meropenem. International journal of clinical pharmacy, 2013, Volume: 35, Issue:3 Topics: Aged; Anti-Bacterial Agents; Anticonvulsants; Bacterial Infections; beta-Lactams; Drug Interactions; Drug Monitoring; Epilepsy; Ertapenem; Humans; Male; Meropenem; Thienamycins; Valproic Acid	2013
Reply to Soman et al and Frippiat et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Female; Humans; Male; Penicillanic Acid; Piperacillin; Sepsis	2013
Are prolonged/continuous infusions of β-lactams for all? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Female; Humans; Male; Penicillanic Acid; Piperacillin; Sepsis	2013
Susceptibility to antibiotics of aerobic bacteria isolated from community acquired secondary peritonitis in children: therapeutic guidelines might not always fit with and everyday experience. Journal of chemotherapy (Florence, Italy), 2013, Volume: 25, Issue:4 Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Gentamicins; Hospitals, Pediatric; Humans; Italy; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Sulbactam; Thienamycins	2013
DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Volume: 58, Issue:8 Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Blood Chemical Analysis; Critical Illness; Female; Humans; Intensive Care Units; International Cooperation; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Prospective Studies; Treatment Outcome	2014
Editorial commentary: Are blood concentrations enough for establishing pharmacokinetic/pharmacodynamic relationships? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Volume: 58, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Critical Illness; Female; Humans; Male	2014
A rapid two-step algorithm detects and identifies clinical macrolide and beta-lactam antibiotic resistance in clinical bacterial isolates. Journal of microbiological methods, 2014, Volume: 102 Topics: Algorithms; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Macrolides; Microarray Analysis; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Time Factors; Transition Temperature	2014
Reply to Rhodes et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Sep-15, Volume: 59, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Critical Illness; Female; Humans; Male	2014
Impact of loading doses on the time to adequate predicted beta-lactam concentrations in prolonged and continuous infusion dosing schemes. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Sep-15, Volume: 59, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Critical Illness; Female; Humans; Male	2014
Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients. Intensive care medicine, 2014, Volume: 40, Issue:9 Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Critical Illness; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Risk Factors	2014
Antibiotic dosing in the critically ill: asking the same questions but expecting different answers. Intensive care medicine, 2014, Volume: 40, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Female; Humans; Male	2014
Membrane active phenylalanine conjugated lipophilic norspermidine derivatives with selective antibacterial activity. Journal of medicinal chemistry, 2014, Nov-26, Volume: 57, Issue:22 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Design; Drug Resistance, Bacterial; Enterococcus faecium; Humans; Kinetics; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Micelles; Microbial Sensitivity Tests; Molecular Conformation; Phenylalanine; Plasma; Serum; Spermidine; Tetrazolium Salts; Thiazoles; Vancomycin	2014
Specific character of anaerobic bacterial infections in patients treated in transplantation wards at one of the clinical hospitals in Warsaw. Transplantation proceedings, 2014, Volume: 46, Issue:8 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Gram-Positive Bacteria; Humans; Imipenem; Immunocompromised Host; Metronidazole; Microbial Sensitivity Tests; Poland	2014
Characterization of a novel small molecule that potentiates β-lactam activity against gram-positive and gram-negative pathogens. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:4 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cell Line; Cell Wall; Colony Count, Microbial; Cytosol; Drug Evaluation, Preclinical; Drug Synergism; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice, Inbred BALB C; Penicillin-Binding Proteins; Quinones; Small Molecule Libraries	2015
Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study. International journal of antimicrobial agents, 2015, Volume: 45, Issue:4 Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cohort Studies; Critical Illness; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Treatment Outcome; Young Adult	2015
Augmented renal clearance and therapeutic monitoring of β-lactams. International journal of antimicrobial agents, 2015, Volume: 45, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Critical Illness; Female; Humans; Male	2015
Subtleties in practical application of prolonged infusion of β-lactam antibiotics. International journal of antimicrobial agents, 2015, Volume: 45, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Humans; Infusions, Intravenous	2015
Prophylactic perioperative antibiotic administration: is it time to infuse our practices with new approaches? Anesthesia and analgesia, 2015, Volume: 120, Issue:4 Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; beta-Lactams; Humans	2015
Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2015, Volume: 21, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Humans; Selection, Genetic	2015
Ertapenem usage in cancer patients with and without neutropenia: a report on 97 cases from a comprehensive cancer center. Infection, 2015, Volume: 43, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Drug Utilization; Ertapenem; Female; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Retrospective Studies; Treatment Outcome; Young Adult	2015
Consequences of avoiding β-lactams in patients with β-lactam allergies. The Journal of allergy and clinical immunology, 2016, Volume: 137, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Hypersensitivity; Female; Hospital Mortality; Humans; Length of Stay; Logistic Models; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Treatment Failure; Young Adult	2016
Metal-based biologically active azoles and β-lactams derived from sulfa drugs. Bioorganic & medicinal chemistry, 2016, Mar-01, Volume: 24, Issue:5 Topics: Anti-Bacterial Agents; Azoles; Bacteria; Bacterial Infections; beta-Lactams; Coordination Complexes; Humans; Ligands; Microbial Sensitivity Tests; Models, Molecular; Schiff Bases; Sulfamethoxazole; Sulfathiazole; Sulfathiazoles	2016
Faropenem Consumption is Increasing in India. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, Apr-15, Volume: 62, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Resistance, Multiple; Drug Utilization; Humans; India; Microbial Sensitivity Tests	2016
Who should receive extended infusion beta-lactam therapy? JAAPA : official journal of the American Academy of Physician Assistants, 2016, Volume: 29, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Humans; Infusions, Intravenous; Patient Selection; Penicillins	2016
Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in Turkey. The Journal of antimicrobial chemotherapy, 2016, Volume: 71 Suppl 1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; Infant; Infant, Newborn; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Turkey; Young Adult	2016
[In vitro activity of ertapenem against clinical bacterial isolates in 69 Spanish medical centers (E-test study)]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2007, Volume: 20, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Ertapenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Spain	2007
[Clinical implications of antibiotic pharmacokinetic-pharmacodynamic parameters]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2008, Volume: 15 Suppl 2 Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Bone Diseases; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation; Drug Resistance, Bacterial; Forecasting; Humans; Injections, Intravenous; Macrolides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Respiratory Tract Infections; Risk Factors; Skin Diseases, Bacterial; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors	2008
Effect of early antibiotic prophylaxis with ertapenem and meropenem in experimental acute pancreatitis in rats. Journal of hepato-biliary-pancreatic surgery, 2009, Volume: 16, Issue:3 Topics: Animals; Antibiotic Prophylaxis; Bacterial Infections; beta-Lactams; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Ertapenem; Male; Meropenem; Pancreatitis, Acute Necrotizing; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Thienamycins	2009
Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus. Pediatrics, 2009, Volume: 123, Issue:6 Topics: Abscess; Adolescent; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Case-Control Studies; Child; Child, Preschool; Clindamycin; Cohort Studies; Drug Therapy, Combination; Emergency Service, Hospital; Empiricism; Female; Hospitalization; Humans; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Philadelphia; Retrospective Studies; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Streptococcal Infections; Streptococcus pyogenes; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult	2009
Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics. The Journal of antimicrobial chemotherapy, 1981, Volume: 8 Suppl B Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Bacterial Infections; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Drug Resistance, Bacterial; Gram-Negative Aerobic Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxalactam; Staphylococcus	1981
The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin. The Journal of antimicrobial chemotherapy, 1981, Volume: 8 Suppl B Topics: Agar; Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ceftazidime; Cephalosporins; Colony Count, Microbial; Female; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests	1981
Accounting for the development of antibacterial resistance in the cost effectiveness of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections in the UK. PharmacoEconomics, 2009, Volume: 27, Issue:12 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cost-Benefit Analysis; Decision Trees; Diabetic Foot; Direct Service Costs; Drug Costs; Drug Resistance, Bacterial; Ertapenem; Humans; Models, Biological; Models, Econometric; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quality-Adjusted Life Years; Treatment Outcome; United Kingdom	2009
Therapeutic drug monitoring of beta-lactams for critically ill patients: unwarranted or essential? International journal of antimicrobial agents, 2010, Volume: 35, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Critical Illness; Drug Monitoring; Humans	2010
Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept. International journal of antimicrobial agents, 2010, Volume: 36, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; APACHE; Bacterial Infections; beta-Lactams; Critical Illness; Drug Monitoring; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome	2010
Bacillus species infective arthritis after knee arthroscopy. Surgical infections, 2010, Volume: 11, Issue:6 Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; Arthroscopy; Bacillus; Bacterial Infections; beta-Lactams; Biopsy, Needle; Female; Fluoroquinolones; Humans; Knee Joint; Treatment Outcome	2010
Course and severity of postpartum metritis cases following antibiotic and PGF2α administration in postpartum metritis cows infected with BoHV-4. Transboundary and emerging diseases, 2011, Volume: 58, Issue:1 Topics: Animals; Antibodies, Viral; Bacteria; Bacterial Infections; beta-Lactams; Cattle; Cattle Diseases; Dinoprost; Female; Herpesviridae Infections; Herpesvirus 4, Bovine; Oxytetracycline; Postpartum Period; Puerperal Infection; Turkey; Uterine Diseases; Vagina	2011
Role of the oral Beta-lactams in the treatment of exacerbations of chronic bronchitis: critical analysis and therapeutics recommendations. Journal of chemotherapy (Florence, Italy), 2010, Volume: 22 Suppl 1 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Bronchitis, Chronic; Humans; Practice Guidelines as Topic; Risk Factors; Survival Rate; Treatment Outcome	2010
Use of empiric antimicrobial therapy in neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee. Internal medicine journal, 2011, Volume: 41, Issue:1b Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Australia; Bacteremia; Bacterial Infections; Bacteriological Techniques; beta-Lactams; Cancer Care Facilities; Disease Management; Drug Resistance, Multiple, Bacterial; Fever; Humans; Immunocompromised Host; Neoplasms; Neutropenia; Risk Assessment; Severity of Illness Index	2011
Evaluation of antimicrobial susceptibility for β-lactams against clinical isolates from 51 medical centers in Japan (2008). Diagnostic microbiology and infectious disease, 2011, Volume: 69, Issue:4 Topics: Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Japan; Microbial Sensitivity Tests; Reproducibility of Results; Staphylococcal Infections; Staphylococcus	2011
An animal farm called extended-spectrum beta-lactamase: antimicrobial resistance as a zoonosis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2011, Volume: 17, Issue:6 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Humans; Zoonoses	2011
On the clinical implications of β-lactam-aminoglycoside synergism. International journal of antimicrobial agents, 2011, Volume: 38, Issue:2 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Humans	2011
[Characteristics of ertapenem use in critical state patients]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2011, Volume: 56, Issue:3-4 Topics: Abdominal Cavity; Adult; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Lung; Microbial Sensitivity Tests; Skin; Time Factors; Tissue Distribution	2011
[Is monotherapy with β-lactam antibiotics still up to date? New aspects for treatment of severe infections]. Deutsche medizinische Wochenschrift (1946), 2012, Volume: 137, Issue:6 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Cell Wall; Critical Care; Cross Infection; Drug Therapy, Combination; Exotoxins; Guideline Adherence; Humans; Immunization; Interleukin-8; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Virulence Factors	2012
Therapeutic drug monitoring of beta-lactam antibiotics in burns patients--a one-year prospective study. Therapeutic drug monitoring, 2012, Volume: 34, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Body Surface Area; Burns; Creatinine; Drug Monitoring; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Time Factors	2012
Case-control study of drug monitoring of β-lactams in obese critically ill patients. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Case-Control Studies; Cefepime; Ceftazidime; Cephalosporins; Drug Monitoring; Enzyme Inhibitors; Female; Humans; Male; Meropenem; Middle Aged; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Replacement Therapy; Sepsis; Shock, Septic; Tazobactam; Thienamycins; Young Adult	2013
β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia. International journal of antimicrobial agents, 2013, Volume: 41, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Critical Care; Critical Illness; Drug Monitoring; Female; Humans; Hypoalbuminemia; Kidney; Male	2013
Tissue pharmacokinetics of ertapenem at steady-state in diabetic patients with leg infections. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:4 Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Diabetic Foot; Ertapenem; Female; Humans; Male; Middle Aged; Plasma; Skin; Young Adult	2013
Living with extended-spectrum β-lactamase: a qualitative study of patient experiences. American journal of infection control, 2013, Volume: 41, Issue:8 Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carrier State; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Health Knowledge, Attitudes, Practice; Humans; Interviews as Topic; Male; Patient Isolation; Professional-Patient Relations	2013
In vitro activity of faropenem against 5460 clinical bacterial isolates from Europe. The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:2 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Europe; Humans; Lactams; Microbial Sensitivity Tests	2002
Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bites. The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:3 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Bites and Stings; Fluoroquinolones; Humans; Lactams; Macrolides; Skin Diseases, Bacterial; Tetracyclines	2002
Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics. Oral microbiology and immunology, 2002, Volume: 17, Issue:5 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroidaceae Infections; beta-Lactams; Cefepime; Cefmetazole; Cefoperazone; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Fusobacterium; Fusobacterium Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Mouth Diseases; Penicillin G; Penicillins; Peptostreptococcus; Porphyromonas gingivalis; Prevotella; Streptococcal Infections; Streptococcus; Sulbactam	2002
Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection. The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:5 Topics: Acute Disease; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests; Pelvic Infection	2002
Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams. International journal of antimicrobial agents, 2002, Volume: 20, Issue:5 Topics: Anaerobiosis; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; beta-Lactams; Ciprofloxacin; Clindamycin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines	2002
In vitro activity of ertapenem against common clinical isolates in relation to human pharmacokinetics. Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Ertapenem; Haemophilus influenzae; Humans; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes	2002
Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against recent clinical isolates from India: a survey of ten medical center laboratories. Diagnostic microbiology and infectious disease, 2002, Volume: 44, Issue:4 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Escherichia coli; Gram-Negative Bacteria; Humans; India; Klebsiella pneumoniae; Microbial Sensitivity Tests; Staphylococcus	2002
Faropenem, a new oral penem: antibacterial activity against selected anaerobic and fastidious periodontal isolates. The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:3 Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Humans; Lactams; Mouth; Periodontal Diseases	2003
In vitro and in vivo activities of AM-112, a novel oxapenem. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:5 Topics: Animals; Bacterial Infections; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactams; Carrier Proteins; Cephalosporins; Drug Therapy, Combination; Enzyme Inhibitors; Hexosyltransferases; Lactams; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases	2003
Antimicrobial activity of beta-lactam antibiotics against clinical pathogens after molecular inclusion in several cyclodextrins. A novel approach to bacterial resistance. The Journal of pharmacy and pharmacology, 2003, Volume: 55, Issue:3 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Chromatography, High Pressure Liquid; Cyclodextrins; Deuterium Oxide; Drug Resistance, Bacterial; Drug Stability; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests	2003
[Evaluation of sensitivity to antibiotics of microorganisms isolated from children with urinary tract infections]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2003, Volume: 14, Issue:82 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; beta-Lactams; Child; Female; Humans; Male; Microbial Sensitivity Tests; Urinary Tract Infections	2003
Activity of faropenem and imipenem for ciprofloxacin-resistant bacteria. The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:3 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Thienamycins	2003
Bactericidal cationic peptides can also function as bacteriolysis-inducing agents mimicking beta-lactam antibiotics?; it is enigmatic why this concept is consistently disregarded. Medical hypotheses, 2004, Volume: 62, Issue:3 Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteria; Bacterial Infections; beta-Lactams	2004
Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Abdomen; Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Ertapenem; Female; Humans; Lactams; Male; Microbial Sensitivity Tests; Middle Aged; Rats	2004
Ertapenem: a new opportunity for outpatient parenteral antimicrobial therapy. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Ambulatory Care; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Infusions, Intravenous; Lactams; Outpatients; Self Administration	2004
Superbugs and Superdrugs: a focus on antibacterials--6th annual SMi conference. Expert opinion on emerging drugs, 2004, Volume: 9, Issue:1 Topics: Amidohydrolases; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Clinical Trials as Topic; Daptomycin; Drug Design; Drug Evaluation, Preclinical; Drug Resistance; Drug Resistance, Multiple, Bacterial; Humans; Ketolides; Marketing; Mice; Protein Synthesis Inhibitors; Ribosomes; Structure-Activity Relationship; Topoisomerase II Inhibitors	2004
Treatment of complicated community-acquired infections with ertapenem, the first Group 1 carbapenem. Introduction. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Carbapenems; Community-Acquired Infections; Drug Resistance, Bacterial; Ertapenem; Humans; Lactams	2004
Relationship between pharmacokinetics and pharmacodynamics of beta-lactams and outcome. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefepime; Ceftriaxone; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Treatment Outcome	2004
In vitro and in vivo activities of novel 6-methylidene penems as beta-lactamase inhibitors. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:12 Topics: Animals; Area Under Curve; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Bridged Bicyclo Compounds; Crystallography, X-Ray; Enzyme Inhibitors; Female; Heterocyclic Compounds; Kinetics; Mice; Microbial Sensitivity Tests; Penicillins; Piperacillin; Rats; Rats, Wistar; Structure-Activity Relationship	2004
Emerging epidemic of metallo-beta-lactamase-mediated resistances. Diagnostic microbiology and infectious disease, 2005, Volume: 51, Issue:2 Topics: Americas; Anti-Bacterial Agents; Asia; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Disease Outbreaks; Europe; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Incidence; Male; Mass Screening; Microbial Sensitivity Tests; Sensitivity and Specificity	2005
[Activity of ertapenem and 19 other antimicrobial agents against beta-lactam-resistant Streptococcus pneumoniae and Haemophilus influenzae respiratory tract isolates]. Enfermedades infecciosas y microbiologia clinica, 2005, Volume: 23, Issue:2 Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Child; Drug Resistance, Multiple, Bacterial; Ertapenem; Haemophilus influenzae; Humans; Lactams; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Respiratory Tract Infections; Spain; Streptococcus pneumoniae	2005
Suspected disk space infection with negative microbiological tests-report of eight cases and comparison with documented pyogenic discitis. Joint bone spine, 2005, Volume: 72, Issue:2 Topics: Abscess; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Discitis; Drug Therapy, Combination; Female; Fluoroquinolones; Fosfomycin; Humans; Injections, Intravenous; Male; Middle Aged; Retrospective Studies; Risk Factors	2005
In vitro evaluation of faropenem activity against anaerobic bacteria. Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:1 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Humans; In Vitro Techniques; Lactams; Microbial Sensitivity Tests	2005
Beta-lactams with or without aminoglycosides. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Nov-15, Volume: 41, Issue:10 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans	2005
Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever. International journal of antimicrobial agents, 2005, Volume: 26 Suppl 2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Drug Therapy, Combination; Fever of Unknown Origin; Guidelines as Topic; Humans; Neoplasms; Neutropenia; Risk Factors; Treatment Outcome	2005
Trough serum concentrations of beta-lactam antibiotics in cancer patients: inappropriateness of conventional schedules to pharmacokinetic/pharmacodynamic properties of beta-lactams. International journal of antimicrobial agents, 2006, Volume: 27, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Drug Administration Schedule; Female; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies	2006
An increased prevalence of {beta}-lactamase-positive isolates in Japanese patients with dentoalveolar infection. The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:3 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; beta-Lactams; Humans; Japan; Periodontal Diseases; Prevalence; Tooth Socket	2006
In vitro activities of ertapenem against drug-resistant Streptococcus pneumoniae and other respiratory pathogens from 12 Asian countries. Diagnostic microbiology and infectious disease, 2006, Volume: 56, Issue:4 Topics: Anti-Bacterial Agents; Asia; Bacterial Infections; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pneumococcal Infections; Respiratory Tract Infections; Sentinel Surveillance; Streptococcus pneumoniae	2006
[Therapeutic antimicrobial agents for postoperative infections: appropriate use of antibiotics from the viewpoint of pharmacokinetic/pharmacodynamic theory]. Nihon Geka Gakkai zasshi, 2006, Volume: 107, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Humans; Postoperative Complications	2006
Bactericidal activity of ertapenem against major intra-abdominal pathogens. International journal of antimicrobial agents, 2006, Volume: 28, Issue:5 Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; beta-Lactams; Ceftazidime; Ceftriaxone; Digestive System Diseases; Enterobacter cloacae; Enterococcus faecalis; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus mirabilis; Staphylococcus aureus; Time Factors	2006
Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial. International wound journal, 2007, Volume: 4, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Diabetic Foot; Ertapenem; Female; Humans; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Severity of Illness Index; Treatment Failure	2007
Comparison of in vitro activities of levofloxacin, ciprofloxacin, ceftazidime, cefepime, imipenem, and piperacillin-tazobactam against aerobic bacterial pathogens from patients with nosocomial infections. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2007, Volume: 40, Issue:2 Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacterial Infections; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests	2007
Comparative costs of ertapenem and piperacillin-tazobactam in the treatment of diabetic foot infections. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, May-15, Volume: 64, Issue:10 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Diabetic Foot; Drug Administration Schedule; Drug Combinations; Ertapenem; Female; Health Care Costs; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2007
Inadequate antimicrobial prophylaxis during surgery: a study of beta-lactam levels during burn debridement. The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:1 Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; beta-Lactams; Burns; Cephalothin; Debridement; Drug Administration Schedule; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam	2007
Comment on: Best in class: a good principle for antibiotic usage to limit resistance development? The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:4 Topics: Bacterial Infections; beta-Lactams; Ertapenem; Humans	2007
National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12 Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Geography; Haemophilus influenzae; Health Surveys; Humans; Moraxella catarrhalis; Penicillin Resistance; Respiratory Tract Infections; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination; United States	2007
Evaluation of antimicrobial susceptibility for beta-lactams using the Etest method against clinical isolates from 100 medical centers in Japan (2006). Diagnostic microbiology and infectious disease, 2008, Volume: 60, Issue:2 Topics: Academic Medical Centers; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Japan; Microbial Sensitivity Tests	2008
Antimicrobial susceptibility and beta-lactamase production of anaerobic and aerobic bacteria isolated from pus specimens from orofacial infections. Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:5 Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Humans; Microbial Sensitivity Tests; Periodontal Diseases; Suppuration; Tooth Diseases	2007
[Recommendations of antimicrobial treatment in patients allergic to beta-lactam antibiotics]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2008, Volume: 21, Issue:1 Topics: Algorithms; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Hypersensitivity; Epitopes; Humans	2008
[Antibacterial activity of N-formimidoyl-thienamycin in comparison with other beta-lactam antibiotics against clinical problem strains (author's transl)]. Arzneimittel-Forschung, 1982, Volume: 32, Issue:6 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Imipenem; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Serratia marcescens; Species Specificity	1982
In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim. Antimicrobial agents and chemotherapy, 1982, Volume: 22, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Trimethoprim	1982
Combinations of beta lactam antibiotics. British medical journal (Clinical research ed.), 1984, Apr-07, Volume: 288, Issue:6423 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Humans; Mice	1984
In vitro and in vivo antibacterial effects of combinations of beta-lactam antibiotics. Antimicrobial agents and chemotherapy, 1981, Volume: 19, Issue:4 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Cephalosporins; Drug Interactions; Male; Mezlocillin; Mice; Penicillins; Piperacillin	1981
Comparative activity in vitro of piperacillin. The Journal of antimicrobial chemotherapy, 1982, Volume: 9 Suppl B Topics: Bacteria; Bacterial Infections; beta-Lactamases; beta-Lactams; Clavulanic Acid; Drug Stability; Drug Synergism; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; R Factors	1982
Bacterial infections of the upper respiratory airways and beta-lactam antibiotics. Scandinavian journal of infectious diseases. Supplementum, 1984, Volume: 42 Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Humans; Laryngitis; Otitis Media; Pharyngitis; Respiratory Tract Infections; Rhinitis; Sinusitis	1984
Beta-lactam antibiotics in lower respiratory tract infections. Scandinavian journal of infectious diseases. Supplementum, 1984, Volume: 42 Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Bronchitis; Humans; Penicillins; Pneumonia; Respiratory Tract Infections	1984
Treatment with beta-lactam antibiotics in skin and soft tissue infections. Scandinavian journal of infectious diseases. Supplementum, 1984, Volume: 42 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Connective Tissue Diseases; Humans; Skin Diseases, Infectious	1984
Better and better beta-lactams. The New Zealand medical journal, 1983, Apr-13, Volume: 96, Issue:729 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; beta-Lactams; Humans; Microbial Sensitivity Tests	1983
Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria. The Journal of antimicrobial chemotherapy, 1981, Volume: 7, Issue:3 Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; Drug Combinations; Female; Humans; Male; Middle Aged; Penicillin Resistance; Urinary Tract Infections	1981
Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria. Antimicrobial agents and chemotherapy, 1982, Volume: 21, Issue:1 Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carrier Proteins; Drug Stability; Female; Hexosyltransferases; Mice; Mice, Inbred Strains; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases	1982
The carbapenem family. The Journal of antimicrobial chemotherapy, 1982, Volume: 10, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; Humans	1982
In-vitro activity of Sch 29482--a new oral beta-lactam antibiotic. The Journal of antimicrobial chemotherapy, 1982, Volume: 9 Suppl C Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Humans; Lactams; Microbial Sensitivity Tests	1982
Comparative activities of 13 beta-lactam antibiotics. Antimicrobial agents and chemotherapy, 1982, Volume: 21, Issue:6 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Humans; Microbial Sensitivity Tests	1982
Third-generation beta-lactam antibiotics for treatment of orthopedic infections. Clinical therapeutics, 1982, Volume: 5, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Bone Diseases; Female; Humans; Joint Diseases; Male; Middle Aged	1982
[Importance and administration of beta-lactam antibiotics in practice]. Die Medizinische Welt, 1982, Aug-13, Volume: 33, Issue:31-32 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ear Diseases; Humans; Pharyngitis; Pneumonia, Pneumococcal; Urinary Tract Infections	1982
In vitro activity of new beta-lactam antibiotics and other antimicrobial drugs against anaerobic isolates from obstetric and gynecological infections. Antimicrobial agents and chemotherapy, 1982, Volume: 22, Issue:4 Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Female; Genital Diseases, Female; Humans; Microbial Sensitivity Tests	1982
Leukopenia in patients with cirrhosis who were treated with beta-lactam antibiotics. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 19, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Humans; Leukopenia; Liver Cirrhosis	1994
In vitro antibacterial properties of T-5575 and T-5578 novel parenteral 2-carboxypenams. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:12 Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carrier Proteins; Ceftazidime; Cephalosporins; Escherichia coli Proteins; Hexosyltransferases; Humans; Lactams; Microbial Sensitivity Tests; Monobactams; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Protein Binding	1995
Comparative in-vitro activities of trovafloxacin, ciproflaxacin, ofloxacin, and broad-spectrum beta-lactams against aerobe blood culture isolates. Zentralblatt fur Bakteriologie : international journal of medical microbiology, 1998, Volume: 288, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Bacteria, Aerobic; Bacterial Infections; beta-Lactams; Blood; Culture Media; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Naphthyridines	1998
[Re-evaluation of the gastrointestinal effects of beta-lactam inhibitors of beta-lactamase]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 1998, Volume: 11, Issue:4 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; Digestive System; Enzyme Inhibitors; Humans	1998
Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group. Diagnostic microbiology and infectious disease, 1999, Volume: 34, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Carbapenems; Enterobacteriaceae; Evaluation Studies as Topic; Gram-Negative Bacteria; Humans; Japan; Microbial Sensitivity Tests; Quality Control; Staphylococcus	1999
In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactams. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2000, Volume: 4, Issue:5 Topics: Bacteria; Bacterial Infections; beta-Lactams; Brazil; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Hospitals, University; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2000
[Beta-lactamases with a wide substrate spectrum in gram negative strictly anaerobic rods]. Medycyna doswiadczalna i mikrobiologia, 2000, Volume: 52, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Gram-Negative Facultatively Anaerobic Rods; Humans; Substrate Specificity	2000
Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infections. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:4 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests	2002
Pharmacokinetics and pharmacodynamics of oral beta-lactam antibiotics as a two-dimensional approach to their efficacy. The Journal of antimicrobial chemotherapy, 2002, Volume: 50 Suppl Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Drug Administration Schedule; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Models, Biological; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes; Time Factors	2002
In vitro activity of ertapenem against bacterial isolates from cancer patients. Diagnostic microbiology and infectious disease, 2002, Volume: 43, Issue:3 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Ertapenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lactams; Microbial Sensitivity Tests; Neoplasms; Staphylococcus; Streptococcus	2002
Nocardicin A, a new monocyclic beta-lactam antibiotic V. In vivo evaluation. The Journal of antibiotics, 1977, Volume: 30, Issue:11 Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbenicillin; Cefazolin; Escherichia coli Infections; Kidney; Liver; Male; Mice; Penicillin Resistance; Proteus Infections; Pseudomonas Infections; Serratia marcescens	1977
A new beta-lactam antibiotic: is it a major advance? Drugs, 1979, Volume: 17, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefoxitin; Enterobacteriaceae Infections; Humans	1979
[Detection of causative bacteria for bovine mastitis and their susceptibility to beta-lactam antibacterial agents]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:10 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cattle; Corynebacterium; Drug Resistance, Microbial; Mastitis, Bovine; Staphylococcus; Streptococcus	1990
Comparative dose-effect relations at several dosing intervals for beta-lactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh-infection and pneumonitis models. Scandinavian journal of infectious diseases. Supplementum, 1990, Volume: 74 Topics: 4-Quinolones; Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; beta-Lactams; Disease Models, Animal; Dose-Response Relationship, Drug; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gram-Negative Bacteria; Least-Squares Analysis; Mice; Mice, Inbred ICR; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Specific Pathogen-Free Organisms	1990
In-vitro activity of a new penem FCE 22101. The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl C Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; beta-Lactams; Carbapenems; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests	1989
In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents. The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl C Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Gram-Positive Bacteria; Microbial Sensitivity Tests	1989
[A comment on the contribution by H. Rosin: "Beta-lactam antibiotics"]. Der Internist, 1989, Volume: 30, Issue:9 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Drug Resistance, Microbial; Humans	1989
Comprehensive evaluation of ciprofloxacin in combination with beta-lactam antibiotics against Enterobacteriaceae and Pseudomonas aeruginosa. Arzneimittel-Forschung, 1986, Volume: 36, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ciprofloxacin; Drug Synergism; Enterobacteriaceae; Male; Mice; Muscles; Pseudomonas aeruginosa; Quinolines; Time Factors	1986
[Comparison of in vitro activity of 4 oral beta-lactams on microorganisms responsible for broncho-pulmonary infections in children]. Pathologie-biologie, 1988, Volume: 36, Issue:5 Pt 2 Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Child; Escherichia coli; Haemophilus influenzae; Humans; In Vitro Techniques; Klebsiella pneumoniae; Microbial Sensitivity Tests; Respiratory Tract Infections	1988
A regional survey of the resistance to beta-lactam antibiotics in clinical isolates of (facultative) aerobic micro-organisms. Drugs, 1988, Volume: 35 Suppl 2 Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacterial Infections; beta-Lactams; Cross-Sectional Studies; Drug Resistance, Microbial; Enterobacter; Escherichia coli; Humans; Klebsiella pneumoniae; Netherlands; Proteus mirabilis; Pseudomonas aeruginosa	1988
[Susceptibility of gram-negative bacterial isolates to six beta-lactam and two aminoglycoside antibiotics at our university hospital]. Journal of UOEH, 1988, Sep-01, Volume: 10, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans	1988
[Infections of the lower respiratory tract--effectiveness of beta- lactam antibiotics on bacterial isolates from sputum and bronchial secretions]. Praxis und Klinik der Pneumologie, 1988, Volume: 42, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Resistance, Microbial; Humans; Pneumonia; Sputum	1988
[Clinical significance of beta-lactamase inhibitors]. Klinische Wochenschrift, 1988, Jan-15, Volume: 66, Issue:2 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; Humans; Microbial Sensitivity Tests; Structure-Activity Relationship	1988
Emergence of resistance to beta-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescens. The Journal of infectious diseases, 1986, Volume: 153, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; beta-Lactams; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Membrane Proteins; Molecular Weight; Serratia marcescens	1986
[Development of resistance to modern beta-lactam antibiotics]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1987, Apr-30, Volume: 107, Issue:12 Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged	1987
Beta-lactam/aminoglycoside combinations: interactions and their mechanisms. The American journal of medicine, 1986, May-30, Volume: 80, Issue:5C Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Blood Bactericidal Activity; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests	1986
[In vitro susceptibility of bacterial isolates from patients with respiratory tract infections to beta-lactam antibiotics]. The Japanese journal of antibiotics, 1986, Volume: 39, Issue:3 Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Child; Child, Preschool; Haemophilus; Humans; Klebsiella; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus	1986
[Antibacterial effect of beta-lactam antibiotics]. Medizinische Klinik (Munich, Germany : 1983), 1986, Feb-28, Volume: 81, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Humans; Microbial Sensitivity Tests	1986
[6R-[(R)-2-[3-[2-(p-Aminosulfonyl)anilino-4-hydroxy-5- pyrimidinyl]ureido]-2-(4-hydroxyphenyl)acetamido]-penicillanic acid, sodium salt (VX-VC 43), a new broad-spectrum beta-lactam antibiotic. In vitro and in vivo antibiotic activity]. Arzneimittel-Forschung, 1985, Volume: 35, Issue:1A Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Bile; Blood Proteins; Dogs; Humans; Hydrogen-Ion Concentration; Mice; Microbial Sensitivity Tests; Penicillins; Rats; Species Specificity	1985
In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic. Antimicrobial agents and chemotherapy, 1985, Volume: 27, Issue:5 Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Infections; beta-Lactamases; beta-Lactams; Drug Stability; Female; Hydrolysis; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Protein Binding	1985
Double beta-lactam therapy in the immunocompromised host. The Journal of antimicrobial chemotherapy, 1985, Volume: 16, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Neutropenia; Sepsis	1985
Current needs for new beta-lactam antibiotics in pediatrics. The American journal of medicine, 1985, Nov-29, Volume: 79, Issue:5B Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child, Preschool; Cystic Fibrosis; Fever; Humans; Infant; Infant, Newborn; Kinetics; Meningitis; Neutropenia	1985
[Effect of beta-lactam antibiotic inactivating substance produced by gram negative rods on the treatment of mixed infection]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1974, Volume: 48, Issue:7 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Cephalosporins; Humans; Penicillin Resistance; Penicillins	1974